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ABSTRACT 
Michael Patrick Conlin: Molecular Mechanisms of Flexibility in Nonhomologous End 
Joining 
(Under the direction of Dale Ramsden)
 
 DNA double strand breaks (DSBs) are highly toxic DNA lesions that play a critical 
role in human health and disease. The ability to repair these lesions is essential in all 
kingdoms of life, and in mammals is primarily attributed to the nonhomologous end 
joining (NHEJ) pathway. NHEJ faces a unique challenge: unlike other forms of DNA 
damage, DSBs are structurally heterogeneous, varying wildly in end chemistry. To 
address this problem, NHEJ has evolved uniquely flexible enzymes: DNA polymerases 
and a DNA ligase that can act on a remarkable variety of substrates, much more so 
than their counterparts in other pathways. The mechanistic basis of this flexibility, and 
its significance to biological repair, are unknown. 
 DNA Ligase IV (LIG4) is the only human DNA ligase that participates in NHEJ, 
and the only one that can efficiently ligate ends across gaps, or with terminal mispairs. 
We show by single-molecule analysis that terminal mispairs lead NHEJ complexes to 
mobilize DNA ends and thereby sample more end alignments. This flexibility is what 
allows LIG4 to join such ends, since pairing flexibility and ligation both require a LIG4-
specific structural motif, insert1. Our work showed that pairing flexibility is what enables 
LIG4 to tolerate a chemically diverse array of substrates, and that this tolerance is 
essential for cells to survive exogenous DNA damage such as ionizing radiation. 
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NHEJ employs two uniquely flexible polymerases to prepare ends for ligation: 
DNA polymerase μ (pol µ) and terminal deoxynucleotidyl transferase (TdT). These 
enzymes act on noncanonical substrates that other polymerases cannot engage. We 
show these polymerases primarily incorporate ribonucleotides (RNA), not 
deoxynucleotides (DNA), during NHEJ, both during repair of chromosome breaks made 
by Cas9 and during V(D)J recombination. These ribonucleotides facilitate NHEJ by 
enabling ligation of ends with adjacent mispairs, and even single strand ligation. 
Supplementing cells expressing TdT with deoxynucleotides thus blocks repair of Cas9-
induced breaks, while ribonucleotide supplementation can improve Cas9-directed 
mutagenesis. Our results indicate cellular NHEJ often involves transiently embedded 
ribonucleotides, which promote flexibility in repair at the cost of more fragile 
intermediates.
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CHAPTER 1: INTRODUCTION 
 
 
 
 DNA double strand breaks (DSBs) are a ubiquitous and highly toxic form of DNA 
damage. These lesions arise from a vast array of sources, including normal biological 
processes and exogenous damaging agents. The frequency and myriad sources of 
DSBs pose a serious threat to cells because unrepaired DSBs can lead to genome 
instability and cell death1,2. Thus, the ability to repair DSBs is essential in all kingdoms 
of life. In mammals, the dominant DSB repair pathway is nonhomologous end joining 
(NHEJ)3. A central challenge for this pathway is that DSBs are highly heterogeneous 
lesions and can have end chemistry that complicates repair4. To address this problem, 
the NHEJ pathway has evolved highly flexible enzymes that work on noncanonical 
substrates in unorthodox ways5. The mechanisms underlying this flexibility and their 
significance for biological repair are poorly understood.  
 
1.1 DNA Double Strand Break Repair Pathways 
In addition to NHEJ, the other main DSB repair pathway is homologous 
recombination (HR)6. HR is a template-based repair pathway: an intact second copy of 
the broken DNA serves as a template for repair. Mechanistically, HR begins with 
nucleolytic resection and proceeds through template-directed synthesis using a 
homologous chromosome or sister chromatid6.  
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A third repair pathway, DNA Polymerase Theta Mediated End Joining (TMEJ), 
typically makes a relatively minor contribution to repair, although it becomes essential in 
the absence of NHEJ or HR7,8. Like HR, TMEJ relies on resection and synthesis to 
repair breaks7. These processing steps effectively convert a DSB into a substrate highly 
amenable to ligation: a simple set of DNA nicks spread apart by fully complementary, 
newly synthesized DNA. Because they involve such extensive processing, HR and 
TMEJ face limitations on when they can be active within the cell9. Moreover, HR 
requires a homologous template and TMEJ requires resected ends with embedded 
homology. In contrast, NHEJ is free from these requirements; it is active throughout the 
cell cycle and capable of robustly repairing DSBs irrespective of any homology9. 
The NHEJ pathway has been highly conserved across evolution and is present in 
bacteria and humans. Hypomorphic mutations in NHEJ genes cause human diseases 
characterized by severe immunodeficiency, cancer predisposition, neurodevelopmental 
disorders, and premature aging10. Repair by NHEJ is sometimes described as error-
prone because it can produce small insertions and deletions at the site of repair11. In the 
event of multiple breaks, NHEJ can also improperly join different chromosomes 
together, producing chromosomal translocations that can lead to cancer12. A key 
challenge facing the NHEJ pathway is that DSBs are highly diverse lesions, both in 
terms of their causes and their chemical structures. 
 
1.2 Sources of DNA Double Strand Breaks 
 Chromosome DSBs arise from a vast array of sources, and are even induced as 
programmed intermediates in biological processes. In meiosis, cells deliberately 
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introduce DSBs that are ultimately responsible for much of the genetic diversity of 
gametes13. Similarly, rearrangement of the variable, joining, and diversity gene 
segments (V(D)J recombination) underlies the vertebrate adaptive immune system and 
proceeds through a DSB intermediate14. However, all DSBs outside of the germline and 
lymphoid tissue are unintended, with dividing mammalian cells encountering around 10 
breaks per cell cycle15. Genome replication is a major source of these breaks, which 
occur when the replication fork encounters DNA damage that cannot be bypassed, or 
when topoisomerase enzymes fail16,17.  
 Outside of those normally encountered throughout biology, the most important 
sources of DSBs are exogenous damaging agents that include some of the most 
commonly used cancer therapies. Ionizing radiation (IR), topoisomerase poisons, and 
many other chemotherapeutics kill cancer cells primarily by inducing DSBs18,19. From a 
biotechnology standpoint, DSBs are an essential tool used to specifically edit the 
genome through guided nucleases, most notably in the CRISPR-Cas9 system20,21. 
 
1.3 Heterogeneity of Double Strand Breaks 
 The many sources of DSBs result in breaks with even more diverse chemical 
structures. Ionizing radiation (IR) alone produces breaks with a wide variety of 
associated oxidative lesions including 5,6-thymine glycol, 5-hydroxymethyl-2’-
deoxyuridine, 5-formyl-2’-deoxyuridine, 8-oxoguanine, and many chemically distinct 
abasic sites22–25. Each of these forms of damage are common and in sum amount to 
well over 1000 lesions per cell per Gray of radiation25. Moreover, IR produces these 
lesions in clusters which often occur at or near the ends of DSBs26,27. Currently there is 
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no way to measure the exact fraction of IR-induced DSBs with associated oxidative 
lesions, but estimates based on lesion frequency suggest the proportion to be around 
one-third of all breaks23. Different sources of ionizing radiation are thought to vary in the 
number and complexity of the oxidative lesions they produce, and thus create DSBs 
with different end chemistry as well28. 
 In contrast with IR, the structures of breaks induced by V(D)J recombination are 
well understood. V(D)J recombination occurs in developing lymphocytes and is 
essential for the adaptive immune system in vertebrates14,29. In this pathway, DSBs are 
intentionally induced by the recombination-activating genes RAG1 and RAG230–32. RAG 
activity leaves one DSB end with a DNA hairpin that is cleaved imprecisely by the 
Artemis nuclease resulting in heterogeneous end structures33. This heterogeneity is 
further augmented by terminal deoxynucleotidyl transferase (TdT, see below)34. The 
corresponding sequence heterogeneity in the repaired products of these breaks gives 
rise to a diverse repertoire of antibody-encoding genes for an effective immune system. 
Repair in V(D)J recombination is carried out entirely by NHEJ and its enzymes function 
in this process largely as they do in nonlymphoid cells35,36. An exception is TdT, a 
specialized DNA polymerase that is only expressed in lymphoid tissue and acts almost 
exclusively during V(D)J recombination37,38.  
 Topoisomerase poisons such as etoposide are some of the most commonly used 
cancer therapy agents. These drugs primarily kill cancer cells by generating DSBs with 
topoisomerase protein adducts that block repair19. In sum, the striking heterogeneity of 
DSBs poses a key challenge to repair pathways in general and NHEJ in particular. 
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1.4 Mechanism of NHEJ 
The diversity of DSBs makes them unlike any other form of DNA damage, and 
the way NHEJ addresses these breaks is fundamentally different from any other repair 
pathway. While HR and TMEJ circumvent the heterogeneity of DSBs by extensively 
resecting breaks to render them simple repair substrates6,7, NHEJ attacks complex 
breaks directly, without resection11,39. To repair such a wide range of substrates, NHEJ 
has evolved extraordinarily flexible enzymes that can act in unique ways and on 
substrates that other enzymes in their respective classes cannot engage5.  
The mechanism of NHEJ proceeds in 4 steps: 1) recognizing and binding the 
DSB, 2) bridging of break ends by the NHEJ paired end complex (PEC), 3) optional 
processing of the ends, and 4) ligation40. The first step, end recognition, is carried out by 
the Ku70/80 heterodimer (Ku)41,42. Ku is often one of the first proteins that binds to the 
ends of a double strand break; its binding then mediates the localization of other NHEJ 
proteins to the break as well43,44. After the NHEJ machinery reaches the break, the ends 
are juxtaposed and held in place to form a paired end complex (PEC)45. At a minimum, 
formation of stable PECs requires the NHEJ ligase, DNA Ligase IV (LIG4), Ku, and the 
scaffold proteins XRCC4 and XLF46–49. The DNA-dependent protein kinase catalytic 
subunit (DNA-PKcs) may also participate in PEC formation50, but its specific role 
remains controversial51.  
Little is known about how efficiently PECs are formed on different kinds of breaks 
(i.e. heterogeneous end structures), the dynamics of the DNA ends and the proteins 
within the complex, and the relationship between PEC formation and ligation51. These 
questions are addressed in Chapter 2. Following PEC formation, NHEJ proceeds either 
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through direct ligation of the ends or optional processing of ends by polymerases or 
nucleases4. 
 
1.5 Rejoining of break ends by DNA Ligase IV 
The ligation step of NHEJ is executed by LIG4, one of three DNA ligases in 
mammals and the only one that participates in this pathway52. LIG4 is an ATP-
dependent enzyme consisting of a 3-domain N-terminal catalytic core and 2 C-terminal 
domains that facilitate its interactions with other NHEJ factors53. The catalytic core of 
LIG4, like those of most other ATP-dependent ligases, consists of a DNA binding 
domain, an adenylation domain containing an active site lysine, and an OB-fold 
domain54.  
DNA ligases have been observed in two structural conformations: a “closed” 
conformation in which the catalytic core domains wrap around a DNA substrate and an 
“open” conformation in which the catalytic core is extended and largely unbound55–57. 
Substrate binding is thought to dictate the transition between these states, and the 
transition is believed to serve as a checkpoint for ligases to interrogate their substrates 
for compatible termini to join58. This mechanism is highly conserved and is employed by 
both bacterial and human DNA ligases; thus, LIG4 likely uses it as well, although this 
remains to be demonstrated structurally. Since LIG4 is required for formation of the 
NHEJ PEC, its open-closed transition is presumably key to stable PEC formation. Other 
ligases probably do not form PECs; if and how LIG4 is specialized to act in this role is 
not understood. 
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After LIG4 engages the DSB ends, its active lysine covalently binds and then 
transfers an adenylate group to the 5’ phosphate of the DSB, which is then resolved by 
nucleophilic attack of the 3’ hydroxyl to form a phosphodiester bond54. LIG4 can carry 
out this chemistry on a remarkable variety of substrates, including ends with mispairs, 
oxidative damage, short patches of single strand DNA, and even 1-2 nucleotide gaps, 
without any processing steps to remove these distortions11,59–61. In contrast, the other 
mammalian ligases, and most ligases throughout biology, are high fidelity enzymes 
unable to join these kinds of end structures60,62. Since the NHEJ ligation step shows low 
fidelity, it is well adapted to the wide array of substrates it must join to allow for efficient 
repair4. This ligase activity is extremely rare in biology; its only precedents are NHEJ 
pathways in other organisms and some viral ligases63,64. While it is clear that NHEJ is 
remarkably flexible in accommodating a wide range of substrates, it is unknown if this 
activity is indeed important for cellular DSB repair in the context of the chromosome. 
The mechanism underlying this flexibility is also unknown, and both of these issues are 
addressed in Chapter 2. In addition to a flexible ligation step, NHEJ also addresses the 
challenge of substrate diversity with a cast of end processing factors that add or 
subtract nucleotides to generate more suitable ligation substrates4. 
 
1.6 End Processing During NHEJ 
 The repair of any single NHEJ substrate can result in a large number of different 
NHEJ products: heterogeneous substrates are repaired into even more heterogeneous 
products11. This product heterogeneity is intrinsically linked to the complexity of the 
original break, with breaks more amenable to ligation producing more homogenous 
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products (e.g. fully complementary overhangs). As the severity of flanking mispairs and 
damage increases, so do the number and frequency of different products recovered11. 
To some extent, this phenomenon reveals the limitations of LIG4 flexibility: some ends 
cannot be tolerated even by such a robust ligase and must instead be processed by 
nucleases and polymerases prior to joining. 
 The Artemis endonuclease is the only nuclease known to act specifically within 
NHEJ33. In fact, an Artemis fragment has been crystallized in complex with a fragment 
of LIG4. Since Artemis cleaves V(D)J recombination intermediates, patients with defects 
in this nuclease are severely immunodeficient65. Nonlymphoid cells derived from these 
patients are sensitive to ionizing radiation, suggesting a role for Artemis in NHEJ 
outside of V(D)J recombination66. Supporting this idea, a recent study showed in vitro 
that Artemis cleaves flaps from 3’ overhangs during NHEJ67. 
 In addition to specialized nucleases, NHEJ has evolved the ability to utilize 3 X-
family DNA polymerases to synthesize nucleotides onto 3’ termini of DSB ends in 
preparation for ligation68. DNA polymerases λ (pol λ), µ (pol µ), and TdT all function in 
this capacity and differ substantially from other polymerases. While replicative 
polymerases are characterized by high fidelity and processivity, NHEJ polymerases lack 
proofreading activity and rarely synthesize more than a few nucleotides69. Moreover, all 
three NHEJ polymerases have N-terminal domains that facilitate their interactions with 
the NHEJ core factors69. In addition to these differences, the NHEJ polymerases 
possess the unique ability to incorporate nucleotides onto noncanonical polymerase 
substrates69,70. Compared with pol λ, pol µ and TdT exhibit activity on an even wider 
spectrum of substrates and show no requirement for a paired primer terminus71. 
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1.7 DNA Polymerase μ and Terminal deoxynucleotidyl Transferase 
 Pol µ and TdT possess noteworthy biochemical properties that render them 
completely unique among nucleic acid polymerases. For instance, pol µ is the only 
eukaryotic polymerase that enables rejoining of non-complementary, broken DNA ends 
absent a paired primer terminus72. The unique ability of pol µ to function in this context 
is evidently dependent upon loop 1, a conserved structural feature unique to the NHEJ 
polymerases73. Additionally, pol µ carries out repair using a distinctive “skip ahead” 
mechanism, wherein the polymerase fills gaps larger than one nucleotide by 
synthesizing only one nucleotide immediately adjacent the 5’ DSB terminus74. 
Consistent with this observation, the biological role of pol µ seems to be the 
incorporation of single nucleotides almost exclusively72.  
 In contrast with pol µ and pol λ, TdT is only expressed in lymphoid tissue and 
participates exclusively in V(D)J recombination75,76. Like pol µ, TdT’s possible primer 
and template exhibit a remarkable level of flexibility71. Unlike all other DNA 
polymerases, TdT synthesizes onto fully single stranded overhangs and is thus fully 
template-independent71,77. In accordance with its role in introducing diversity during 
V(D)J recombination, TdT will polymerize multiple nucleotides onto its primer78. Through 
their unique biochemical activities, pol µ and TdT promote immune system diversity and 
cellular radioresistance34,79–82. Investigations into the biochemical properties of these 
polymerases have therefore focused on explaining these biological roles. 
 Perhaps the most intriguing and poorly understood biochemical property of pol µ 
and TdT is their relatively low sugar selectivity in vitro. Generally, DNA polymerases 
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discriminate against incorporating ribonucleotides into the genome, with at least a 
1,000-fold preference for deoxynucleotides83–85. This discrimination is vital because 
genomic ribonucleotides are toxic and the pathway that removes them is essential in 
mammals86. Surprisingly, TdT and pol µ demonstrate sugar selectivity 200-fold lower 
than other polymerases, and only prefer deoxynucleotides about 5-fold more than 
ribonucleotides37,87–90. It is unclear if these polymerases incorporate ribonucleotides into 
the genome in cells or if their lack of sugar selectivity serves any biological role 
whatsoever88. An investigation of this phenomenon is the subject of Chapter 3. 
 
1.8 Summary 
 The NHEJ pathway must successfully repair a wide range of chromosome break 
substrates to promote genome stability. The DNA ligase and DNA polymerases 
employed by this pathway are the most flexible enzymes in their respective classes, in 
terms of their ability to act on unorthodox substrates5. The mechanisms underlying this 
flexibility are poorly understood and it is unclear if they are important for repair in cells. 
My work has focused on answering these questions, initially focusing on the ligation 
step (Chapter 2) and then on the interaction between polymerases and the ligation step 
(Chapter 3).  
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CHAPTER 2: MECHANISM OF LIGATION FLEXIBILITY IN NHEJ 
 
2.1 Introduction 
DNA double-strand breaks (DSBs) are genomic lesions that play an important 
role in human health and disease. They are frequently generated by exogenous 
damaging agents (e.g. ionizing radiation) or as programmed intermediates in meiosis 
and V(D)J recombination15. The ends generated by these biological sources of 
chromosome breaks are often “complex,” with DNA helix-distorting nucleotide damage, 
mismatches, or chemical adducts that pose challenges to the ligases and polymerases 
needed for DSB repair91. This problem is especially relevant to the nonhomologous end 
joining (NHEJ) pathway since, unlike other DSB repair pathways, these complex ends 
are not extensively resected prior to synthetic steps (polymerase and ligase activity).  
Ligation is the only essential step in NHEJ, and is performed by one of the three 
mammalian ligases, DNA ligase IV (LIG4)52. LIG4 is recruited to broken ends through 
participation in a complex of core NHEJ factors including XRCC4, the Ku 70/80 
heterodimer (Ku)44, and XLF.  This NHEJ core complex is sufficient to physically link a 
pair of broken ends together, and can thus be termed the paired end complex, or PEC.  
The PEC is essential for repair of diverse end structures; for example, XLF is required 
both for stable PEC formation51 and ligation of complex ends, but only modestly affects 
ligation of ends with complementary termini59,61,92. Recent physical analyses of PECs 
indicate that they are highly dynamic51 and that both the flexibility and stability of PECs 
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can be modulated by ligation-compatible DNA end chemistry93. However, it is unclear 
how differences in end structure trigger these changes in dynamics, and whether these 
changes in dynamics impact cellular repair.  
Here we address this problem by assessing the impact of diverse end structures 
on in vitro functional assays, single-molecule analyses of end-pairing dynamics, and 
cellular repair and survival. We show that mismatches near strand break termini trigger 
extensive PEC remodeling. Moreover, a separation-of-function mutation in LIG4 links 
this mispair-induced PEC remodeling to the sensing of these end structures by LIG4, 
and argues PEC remodeling is essential to the proficiency of cellular NHEJ in repairing 
these end structures. 
 
2.2 Methods 
DSB Substrates 
 DSB substrates were made by ligating the 15-30 bp double stranded 
oligonucleotide “caps” described in Table 2.1 to a 285-bp PCR-generated common DNA 
“core” segment that had been digested with BsaI to generate appropriate sticky ends. 
Substrates were purified with the QiaQuick PCR purification kit (Qiagen), 5’ 
phosphorylated with T4 polynucleotide kinase (NEB), and substrate assembly validated 
by gel electrophoresis.  
DNA Constructs and Protein Purification 
 Constructs for expression after baculovirus delivery of human Ku, XLF, XRCC4, 
and LIG4WT into Hi-5 insect cells have been previously described71,94. LIG4∆i was 
generated by modifying LIG4WT as noted in Figure 2.1A and validated by sequencing. 
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The LIG3+4 chimera was generated by replacing amino acids 1-638 of LIG4WT with a 
fusion of amino acids 170-862 of human LIG3 to the linker (GGGGS)x3 (Genewiz). Cell 
pellets were extracted, lysed by sonification, and purified by sequential chromatography 
on Histrap and MonoQ columns (GE Biosciences).  Figure 2.1A structures were 
prepared in Pymol and include hLIG1 (1X9N)56, hLIG3 (3L2P)55, and hLIG4 (3W1B)95, 
with disordered insert1 modeled by the SWISSmodel server96. 
in vitro Joining Assays 
 NHEJ reactions were initiated by incubating 2 nM DSB substrates, 25 nM Ku, 40 
nM XLF, and 40 nM XRCC4-LIG4 in a buffer with 25 mM Tris pH 7.5, 100 uM EDTA, 1 
mM DTT, 5 mM MgCl, 100 uM ATP, 150 mM KCl, 8.5% polyethelene glycol 3000, and 
100 ng of supercoiled plasmid DNA. Reactions were carried out for 10 minutes at 37 C 
and stopped with 0.1% SDS and 20 mM EDTA. Repair products were purified by 
phenol-chlorform extraction and recovery was measured by real-time PCR (qPCR) 
using a QuantStudio 6 system (Applied Biosciences), primers that amplify head-to-tail 
junctions (Table 2.1), and VeriQuest SYBR Green master mix (Affymetrix). The relative 
numbers of molecules recovered were quantified by a well characterized qPCR 
assay11,72. 
For nick sealing assays, a 5’Cy5 labeled, nicked 41 bp substrate was generated 
by annealing three oligonucleotides (Table 2.1). 5 nM substrate was incubated with 
XRCC4-LIG4 at 37 C and products were characterized by denaturing polyacrylamide 
gel electrophoresis (PAGE). Wild-type XRCC4-LIG4 was titrated to determine that 0.5 
nM ligase (1:10 enzyme:substrate) generates sub-saturating  (19-21%) amounts of nick 
sealing in 10 minutes, after which reactions were carried out under these conditions in 
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triplicate to generate data presented in Figure 2.2B. Reaction velocity was determined 
by quantifying band intensities using ImageJ software. 
Electrophoretic Mobility Shift Assay (EMSA) 
 Substrates for EMSA were generated by annealing oligonucleotides (Table 2.1) 
to produce a Cy5 labeled 15 bp substrate to assess DSB end binding (Figure 2.2C), as 
well as a Cy5 labeled, 60 bp substrate to assess complex formation (Figure 2.2D).  To 
assess intrinsic end binding, the 15 bp substrate was incubated at 10 nM with 125, 250, 
or 500 nM XRCC4-LIG4. For complex formation, the 60 bp substrate was incubated at 
10 nM with 2 nM Ku, 40 nM XLF, and 40 nM XRCC4-LIG4. These samples were 
incubated for 20 min on ice in EMSA buffer (50 mM NaCl, 75 mM KCl, 25 mM Tris pH 8, 
13% Glycerol, and 0.015% X100). Samples were run on 4% (Figure 2.2C) or 6% 
(Figure 2.2D) polyacrylamide gels in 0.5x TBE buffer and imaged using a Typhoon 
(GE).  
smFRET Assays 
smFRET assays and analysis were performed as described previously51,93. 
Briefly, NHEJ reactions composed of 50 nM Ku, LX, XLF gloxy (0.5 mg/mL glucose 
oxidase and 0.4 μg/mL catylase), and 1 nM dsDNA were added stepwise to NEB4 (20 
mM pH 7.5 TricAc, 50 mM KAc, 10 mM MgAc) supplemented with 0.8% glucose, ~5 
mM Trolox, 1 mg/mL BSA, and 2 mM DTT. The reaction was immediately flowed into an 
imaging chamber that had been prepared with surface dsDNA (~250 pM). Movies 
consisting of 1000 frames (33Hz) were acquired for analysis of PECs. Trajectory 
analysis, histogram assembly, and autocorrelation of PECs were performed in Matlab93. 
Oligonucleotides used in smFRET experiments are detailed in Table 2.1. 
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Cell Lines 
 LIG4-/- cells were generated from parental HCT116 human colorectal cancer cells 
by conventional gene targeting and were the gift of Dr. Eric Hendrickson97. We 
generated additional variants of the parental cells by CRISPR/Cas9 gene targeting. We 
introduced by electroporation plasmids to express Cas998 (Addgene 44758; 5 µg) and 
an sgRNA99 (Addgene 51133; 5 µg; guide sequence described in Table 2.1) that targets 
insert1-encoding sequence from wild-type LIG4, as well as a gene-targeting donor 
plasmid. The donor plasmid was engineered such that it contains 1.1kb of sequence 
identical to the LIG4 gene except as modified such that gene targeting ablates the 
sgRNA target site, generates the LIG4∆i mutation as described in Figure 2.1A, and 
introduces synonymous mutations that result in a BsmFI site used for screening. The 
native LIG4 sequence in this region and resulting LIG4∆i alleles are described in Figure 
2.6 and Table 2.1. Targeted puromycin resistant clones were identified by amplification 
of the insert1 region using primers specific to the native locus (i.e. originate outside of 
donor sequence identity). Two independently generated clones, LIG4∆i/∆i a and b, were 
produced that possessed only targeted alleles after sequencing (Figure 2.6A). To 
generate LIG4+r/+r reverted cells we repeated gene targeting, but started with LIG4∆i/∆i a 
cells and used an sgRNA specific for the LIG4∆i allele (Table 2.1) as well as a gene-
targeting donor with wild-type sequence in this region.  
We verified LIG4 expression in all of these cell lines using standard western blot 
techniques (Figure 2.6B) and antibodies against human LIG4 (Serotec cat no. AHP554) 
and human Ku70 (Abcam cat no. ab62820). All 5 cell lines were cultured in McCoy’s 5A 
medium (Corning) with 10% fetal bovine serum (Sigma) and determined to be free of 
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mycoplasma contamination by PCR100; we additionally employed a third party to 
validate the absence of mycoplasma by an alternate method for a randomly selected 
cell line (Hoechst staining)101.  
Cellular NHEJ Assays 
Extrachromosomal DNA substrates described above (20 ng) were electroporated 
into 2 x 105 cells with pMAX-GFP plasmid (600 ng) at 1350 V in one 30 ms pulse in 10 
µL (Neon, Invitrogen). Transfected cells were incubated for 30 minutes in antibiotic-free 
McCoy’s 5A media with 10% fetal bovine serum. Cellular repair products were 
harvested using a QIAamp DNA mini kit (Qiagen). Each electroporation was reproduced 
in triplicate from 3 independent preparations of cells. Repair efficiency was quantified by 
qPCR as described above for in vitro joining assays.  
Repair product structures were determined by restriction digest for the 8-
oxoguanine (2-Amino-7,9-dihydro-1H-purine-6,8-dione; Go) substrate, and by high-
throughput sequencing for all other substrates. For the Go substrate, harvested repair 
products were amplified with Cy5-labeled primers (Table 2.1) and digested with BstZ17I 
(New England Biolabs; recognizes transversion mutation after amplification of Go) and 
BamHI (New England Biolabs; recognizes accurately amplified Go) to identify directly 
ligated products. The intensities of digested and undigested bands were quantified 
using ImageJ. 
To determine repair product structures of all other substrates, sequencing 
libraries were prepared by PCR amplification of repair products with primers containing 
6-nucleotide indices on their 5’ ends (Table 2.1). Amplified DNA (40 ng per library) was 
pooled into groups of 8-12 libraries, 5’ phosphorylated, and treated with Klenow exo- 
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(NEB) to add dA to the 3’ termini. Ends were ligated to adapters for paired-end 
sequencing (Illumina). Pooled libraries were purified from 3% agarose gels to remove 
unligated adapters using the QIAquick gel extraction kit (Qiagen). Recovered samples 
were amplified for an additional 9 cycles using enrichment primers (Illumina). Products 
were again purified using Ampure XP beads (Beckman Coulter). 27.27 ng from each of 
the 11 pools was combined (for a total of 300 ng of sample), supplemented with 
PhiX174 (40% final concentration) and submitted to the UNC high throughput 
sequencing facility for a 2 x 75-bp MiSeq run (Illumina). Genomics Workbench was 
used to remove PhiX174 DNA, merge read pairs, de-index libraries, and remove low 
quality sequences (CLC-Bio). Remaining sequences were analyzed using Microsoft 
Excel. 
Colony Formation and Cell Growth Assays 
For colony formation assays, seeding densities were determined independently 
for each dose and cell line such that 50-150 colonies would be produced per 10 cm 
dish. Cells were plated on 10 cm dishes in fresh McCoy’s 5A media with 10% fetal 
bovine serum, incubated for 4 hours, and then irradiated with indicated doses of X-rays 
using a RS 2000 irradiator (Rad Source Technologies). Colonies formed after 14 days 
were stained with a solution of crystal violet (0.5%) and glutaraldehyde (6%). Colonies 
were manually counted on three plates per dose and cell line. The surviving fraction of 
LIG4-/- cells treated with 3 Gy of X-rays was much less than 10-3, and was excluded from 
analysis because the resulting faint, small colonies could not be reliably discriminated 
above background debris staining. 
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For live cell imaging, 2000 cells were plated into 96-well plates in triplicate for 
each dose and cell line. After overnight incubation, cells were irradiated or treated with 
etoposide and placed into the IncuCyte live cell imager (Essen biosciences). Four 215 
mm2 images were taken per well at 10x objective every 4 hours for a total of 120 hours. 
The confluence of each image was determined by generating a confluence mask with 
IncuCyte software (Essen biosciences). 
Statistical Analysis 
For all experiments, means were tested for significance against a control (e.g. 
LIG4WT, LIG4+/+ cells) using two-tailed t-tests for single comparisons, one-way ANOVA 
for multiple comparisons, and two-way ANOVA for comparisons with multiple variables. 
Dunnett’s correction for testing multiple hypotheses was applied as necessary. For each 
experiment, the value and definition of n, the representation of error bars, the specific 
tests used, the specific control tested, and the determination of statistical significance 
are described in the figure legends.  
 
2.3 Results 
LIG4 is specialized to directly ligate mismatched or damaged ends 
Activity of all three mammalian ligases requires the encircling of double stranded 
DNA at a strand break54. Structural studies identified 6-10 amino acids inserted in LIG4 
orthologs (residues 113-122 in human LIG4), relative to other eukaryotic ligases (Figure 
2.1A; Figure 2.2A)95. This insert is located within the strand break-bound ligase on the 
opposite side of the double helix from the strand break and site of catalysis, suggesting 
a possible function specific to substrates with double helix-distorting mispairs or 
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damage. Consistent with this idea, we purified LIG4 with this element specifically 
deleted (LIG4∆i) in a complex with XRCC4. We determined that insert1 had no 
significant impact on LIG4-XRCC4 intrinsic nick sealing activity (Figure 2.2B), DNA 
binding (Figure 2.2C), or ability to form a higher-order complex with NHEJ core factors 
Ku and XLF on DNA (Figure 2.2D). In vitro NHEJ activity was also similar comparing 
LIG4∆i to LIG4WT when ends had complementary overhangs (Figure 2.1B; 5’ G:C, 3’ 
G:C). In contrast, when ends had mispairs or damage at strand-break termini, in vitro 
NHEJ activity using LIG4∆i was reduced 21-66-fold relative to LIG4WT (Figure 2.1B; 5’ 
GoxC, 3’ GxT, 3’ GxA). LIG4∆i is thus specifically defective in supporting in vitro NHEJ 
when substrates have helix-distorting 8-oxoguanine (Go) damage or mispairs near 
strand termini.  
Ends with mispaired nucleotides are critical NHEJ substrates that arise during 
V(D)J recombination and after nucleolytic processing of radiation-induced breaks. They 
also presumably act as a model for ends with other sources of helical distortion, 
including nucleotide damage. To validate this inference, we measured in vitro NHEJ of 
ends with 8-oxoguanine (Figure 2.1B, 5’ GoxC), the most common form of oxidative 
base damage. NHEJ activity on this substrate was reduced over 50-fold with LIG4∆i, 
which was comparable to the effect of a terminal G:A mispair. Therefore, insert1 is 
required for direct ligation of end structures with flanking helical distortions, whether the 
distortions are due to mispairs or nucleotide damage.  To further explore the extent to 
which ligation of ends with terminal mispairs or damage is specific to wild-type LIG4, we 
generated a chimera (LIG3+4) with all three LIG4 catalytic sub-domains replaced with the 
equivalent sub-domains from mammalian wild-type LIG3 (Figure 2.2E). Like LIG4∆i, 
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LIG3+4 physically associates with XRCC4 and was fully competent in Ku- and XLF-
dependent ligation of ends with complementary overhangs. However, end joining with 
this chimera was even more sensitive than LIG4∆i to terminal nucleotide damage 
(activity reduced more than 100-fold, relative to LIG4WT; Figure 2.2E). This result 
consistent with the argument that LIG4 is unique amongst mammalian ligases in its 
ability to repair damaged termini. Additionally, the impact of LIG4∆i on repair of damaged 
ends is less severe than that of the LIG3+4 chimera, suggesting that insert1 is not 
entirely responsible for the unique ability of LIG4 to tolerate mispairs and damage. We 
therefore sought to use the LIG4∆i separation-of-function mutation to investigate both 
the mechanistic basis for the unique ability of NHEJ to tolerate helix-distorting mispairs 
or damage at the ligation step, as well as its significance to cellular double strand break 
repair.  
Dynamic re-alignment of mismatched ends is required for their ligation 
We previously described a single-molecule fluorescent resonance energy 
transfer (smFRET) assay that reports on pairing of DNA ends as mediated by a 
complex of Ku, XRCC4, LIG4, and XLF51,93. These PECs are apparent as FRET pairs 
generated when a Cy3 labeled donor dsDNA fragment in solution stably associates with 
a Cy5 labeled acceptor dsDNA fragment immobilized on a surface (Figure 2.3A). In 
accord with the in vitro ligation assay, LIG4∆i and LIG4WT similarly promote stable PEC 
formation when ends have complementary 4-nucleotide overhangs (G:C, Figure 2.3B). 
In contrast, pairing of overhangs with 3’ terminal G:T mismatches is significantly 
reduced when comparing LIG4Δi to LIG4WT; this reduced pairing efficiency represents a 
diminished proportion of DNA ends associated in the PEC. The formation of PECs is 
  21 
even less efficient when termini have a bulkier purine:purine G:A mismatch, but is 
similarly inefficient for both LIG4WT and LIG4Δi (Figure 2.3B). PECs thus form less 
efficiently with increasing terminal helical distortion, and PECs formed with LIG4∆i are 
more sensitive to this challenge. 
Changes in FRET efficiency (EFRET) reflect dynamic repositioning of DNA ends 
relative to each other within individual PECs51,93. When using complementary ends (3’ 
G:C; Figure 2.3C), EFRET distributions were not significantly different when comparing 
PECs formed with LIG4WT (black line) vs. LIG4∆i (orange line). LIG4∆i PECs also had 
similar FRET distributions when ends had terminal mispairs (Figure 2.3C); importantly, 
LIG4WT PECs formed on ends with mispaired termini more often had lower EFRET (DNA 
labels located further apart; black lines for G:A and G:T mispairs, Figure 2.3C), and 
consequently overall wider distributions of EFRET (Figure 2.3C; Figure 2.4A) when 
compared to paired temini (G:C). Ends with terminal distortions thus trigger PECs to 
sample a wider variety of end-alignment configurations to remain efficiently paired, but 
only when using LIG4WT. 
Examination of smFRET trajectories from individual PECs also shows the 
transition frequency between FRET states increases when comparing LIG4WT and 
LIG4∆i (Figure 2.3D, Figure 2.4C). We quantified this difference by using autocorrelation 
of individual FRET trajectories to calculate the average transition times - “lag times” (τ) - 
between FRET states93. For ends with G:T mismatches, these were approximately two-
fold lower for PECs formed with LIG4WT, compared to PECs formed with LIG4∆i (Figure 
2.4B). These values are then used to calculate the relative stability of the DNA ends in 
the PECs (Figure 2.4C). From these calculated end stabilities we can infer that LIG4WT 
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PECs have lower energetic barriers in assuming new conformations, compared to 
LIG4∆i PECs, but again only when ends have terminal mismatches. 
PECs containing LIG4∆i and mispaired ends are thus formed less efficiently 
(Figure 2.3B), and even when formed do not acquire the high degree of conformational 
plasticity observed when PECs are formed with LIG4WT (Figure 2.3C-D, Figure 2.4D-E). 
We argue the inability of LIG4∆i to allow for mispair-induced PEC remodeling accounts 
for its specific defect in direct ligation of such end structures (Figure 2.1B). There are 
also limits to the extent to which remodeling enables ligation, as even LIG4WT is 
inefficient in joining ends with bulky G:A mismatches (Figure 2.1B). PECs formed with 
paired termini favor a narrow distribution of high FRET end alignments that more closely 
resemble FRET distributions observed with products of ligation93; these alignments thus 
likely directly juxtapose strand-break termini in anticipation of catalytic steps (“pre-
catalytic”, Figure 2.3E). We attribute the LIG4WT-specific, insert1-dependent flexibility in 
accommodation of mispaired termini to a favoring of end alignments that both have 
lower FRET (more distally-located labels) and are more dynamic. These more dynamic 
and lower FRET PECs – “remodeling PECS” - may be catalytically incompetent, but 
allow for iterative attempts at the now transient (but occasionally catalytically 
competent) high-FRET intermediate (Figure 2.3E). 
Cellular NHEJ of complex ends requires remodeling of the PEC 
We next addressed whether the differences in PEC flexibility described above 
significantly impact cellular NHEJ. We employed scar-free gene targeting to exchange 
LIG4WT for LIG4∆i alleles within the native LIG4 locus of a human cell line (Figure 2.5A). 
We independently generated two such cell lines (LIG4∆i/∆i a and LIG4∆i/∆i b), and 
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confirmed they express only LIG4∆i from endogenous loci (Methods; Figure 2.6A-B). We 
then generated a cell line by another round of gene targeting where the LIG4 locus of 
LIG4∆i/∆i a was reverted back to wild type sequence (LIG4+r/+r), as a means of assessing 
the effects of possible off-target mutations incurred in the original round of gene 
targeting (Figure 2.5A, Figure 2.6A-B). Both LIG4∆i/∆i subclones acted equivalently in 
functional assays below. Similarly, results using parental wild type cells (LIG4+/+) 
matched those from the LIG4+r/+r reversion, confirming the differences observed in the 
LIG4∆i/∆i cells could be attributed to the 8 amino acids deletion. 
DSB substrates with varied end structures were introduced into these cells, after 
which efficiency of repair was determined by qPCR and product structures were 
characterized by high-throughput sequencing. In accord with in vitro results, ends with 
complementary overhangs were efficiently joined almost entirely by direct ligation in 
both wild-type and LIG4∆i/∆i cells (Figure 2.5B). Also in accord with in vitro data, ends 
with terminal G:T mispairs were efficiently repaired by direct ligation (accounts for 60% 
of all repair) in both LIG4+/+ and LIG4+r/+r cells, while this class of product is rarely 
(<10%) seen in  LIG4∆i/∆i clones (Figure 2.5C). Instead, repair in LIG4∆i/∆i cells typically 
requires re-alignment of overhangs and gap-repair synthesis prior to ligation of the now 
“sticky” end. This alternate pathway is sufficient to fully compensate for the inability of 
LIG4∆i to directly ligate terminal mispairs, since overall joining efficiency was 
comparable for LIG4+/+ vs.  LIG4∆i/∆i cells.  Considering repair of ends with bulkier G:A 
mispairs, both wild-type and LIG4∆i/∆i cells rely on this compensating pathway (Figure 
2.6C), consistent with in vitro observations that neither LIG4WT nor LIG4∆i can ligate this 
substrate in the absence of end processing. Repair of NHEJ substrates was severely 
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reduced in LIG4-/- cells (Figure 2.5C; approximately 0.0005 products per cell), to the 
extent that we could not recover sufficient repair products to accurately assess product 
spectra. 
Additional substrates were introduced into cells to assess whether barriers to 
mispair tolerance are routinely bypassed by cellular end processing. Similar to 3’ G:T 
mispairs, ends with 5’ Go terminal damage are primarily repaired by direct ligation in 
LIG4+/+ cells. Importantly, joining of 5’ GoxC in LIG4∆i/∆i cells is over 10-fold less efficient 
(Figure 2.5D), even though what little repair does occur is processing-dependent 
(Figure 2.6D). We also investigated cellular NHEJ of end structures with entirely non-
complementary overhangs (TTTT). Joining efficiency was again severely reduced in 
LIG4∆i/∆i cells, relative to wild-type cells (Figure 2.5D). For this substrate, the rare 
products recovered from LIG4∆i/∆i cells only subtly differed from wild-type controls in 
terms of junction structure (Figure 2.6E). Thus, in contrast to previously tested 
substrates (Figure 2.5C), end processing was not sufficient to rescue repair of TTTT 
and 8-oxoguanine substrates in LIG4∆i/∆i cells. We initially linked LIG4WT PEC flexibility 
only to the ability of cellular NHEJ to directly ligate ends with terminal mispairs (Figures 
2.1, 2.3, 2.5C); these latter results identify additional important contributions to cellular 
NHEJ associated with end processing. 
PEC remodeling guides end processing choice during cellular NHEJ 
 We generated the substrate “EC1” (embedded complementarity 1) to further 
explore the relationship between PEC flexibility, cellular end processing, and ligation. 
EC1 has long (10-nt) non-complementary overhangs that can plausibly be aligned to 
juxtapose mispaired 3’OH:5’P termini, in anticipation of direct ligation (Figure 2.7A). 
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Alternatively, EC1 can be re-aligned to pair complementary sequence embedded within 
the overhang, where unpaired tails are a presumptive substrate for nucleolytic end 
processing. These two alignments are readily distinguished by smFRET (Figure 2.8A); 
PECs formed with a control substrate (with fully complementary 10nt overhangs) had 
low EFRET ranges, expected for EC1 alignments that juxtapose 3’OH:5’P termini (green 
lines), while PECs formed with 4-nt complementary overhangs had a clearly distinct 
population of high EFRET (blue lines) expected for EC1 alignments that pair embedded 
complementary sequence. Analysis of individual smFRET trajectories of PECs formed 
with EC1 and NHEJ core factors identified a much larger than typical fraction of 
transient complexes (lifetimes <5 seconds; Figure 2.7B). Transient PECs had two 
distinct populations of EFRET distributions, each roughly corresponding to the two 
alignment classes predicted above (Figure 2.7C). Long-lived PECs (persistent) favor 
only the high EFRET state, but sample both a wider range of alignment configurations 
(Figure 2.7C) and are more dynamic (have lower energetic barriers to transition; Figure 
2.8B) than PECs formed with complementary overhangs. To further address if the 
persistent PECs frequently involve pairing at embedded complementary sequence (as 
suggested by comparison to substrate standards; Figure 2.7C) we used a substrate 
where the complementary sequence was both reduced and re-located (“EC2”). As 
expected, PECs formed less efficiently with EC2 (Figure 2.8C), and when formed had 
mostly lower EFRET (Figure 2.8D). Importantly, LIG4∆i was largely unable to form PECs 
with the EC1 substrate (Figure 2.7D), and the rare PECs that do form primarily have 
intermediate EFRET states that are inconsistent with either alignment (Figure 2.8E). 
Therefore, only LIG4WT effectively promotes end-pairing of this substrate. Moreover, 
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PECs formed with LIG4WT that juxtapose strand termini were “filtered out"; only the most 
plausibly productive alignments, i.e. those that could lead to ligation after nucleolytic 
end processing, were stable (Figure 2.7C).  
We next assessed how the EC1 substrate was resolved by cellular NHEJ. Nearly 
all products (>99%) were indeed consistent with ligation after nuclease activity, with the 
dominant product guided by the alignment at embedded complementary sequence also 
favored in smFRET analysis (Figure 2.8F). By comparison, direct ligation of EC1 
accounted for less than 0.1% of all cellular repairs. Importantly, joining efficiency of this 
substrate was reduced over 60-fold in LIG4∆i/∆i cells, relative to LIG4+/+ cells (Figure 
2.7E), even though LIG4∆i/∆i cells are fully proficient at ligating the inferred product of 
alignment-guided nuclease activity (a 4bp complementary overhang; Figure 2.5B). This 
result suggests that for this substrate, LIG4∆i fails to efficiently mediate repair because it 
is defective at an earlier step than ligation – specifically, stable accommodation of end-
alignments required for nucleolytic end processing (Figure 2.7D).  
Cellular radioresistance requires tolerance of complex ends by LIG4 
LIG4WT thus uniquely accommodates diverse end structures during end pairing. 
However, there is wide variation in how this flexibility impacts cellular NHEJ. Depending 
on the starting end structure it can be dispensable (Figure 2.5B, Figure 2.6C), alter 
product spectra (Figure 2.5C), or can be critical for efficient repair (Figure 2.5D-E, 
Figure 2.7E). We therefore addressed the extent to which the inability of LIG4 to tolerate 
structural diversity impacts cell growth and survival after ionizing radiation. Using both 
standard colony forming assays and real-time imaging of cell growth, LIG4+/+ and 
LIG4+r/+r cells were similarly resistant to increasing dose of ionizing radiation. By 
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comparison, LIG4∆i/∆i cells were radiosensitive to a degree intermediate between LIG4+/+ 
and LIG4-/- cells (Figure 2.9, Figure 2.10), a result strikingly similar to joining efficiencies 
described for the majority of substrates with complex ends (Figure 2.5D-E, Figure 2.7E). 
In contrast with ionizing radiation, LIG4∆i/∆i and LIG4+/+ cells are equally resistant to 
etoposide (Figure 2.10). This is consistent with specific requirement for insert1 in repair 
of ends with mispairs or damage, since etoposide induced breaks can be processed by 
tyrosine phosphodiesterase 2 such that overhangs are undamaged and fully 
complementary102. These results show that the ability of LIG4 to sense distortions 
facilitates cell survival following treatment with ionizing radiation. 
 
2.4 Discussion 
Repair by NHEJ implicitly requires the pairing together of broken chromosome 
ends. A complex of Ku, XRCC4, DNA Ligase IV, and XLF (paired end complex, or PEC) 
is necessary and sufficient for this purpose51; we describe here dynamic changes in this 
complex that are triggered by differences in end structure, and show that this response 
is essential for efficient cellular repair.  
Mechanistic basis for repair of complex ends by NHEJ 
Ends with complementary (“sticky”) overhangs are aligned efficiently and with 
little mobility, to the extent that pairing EFRET more closely resemble the narrow 
distributions observed in products of ligation, relative to other end structures tested 
here. We suggest these PECs describe “pre-catalytic” end alignments, where strand 
break termini are directly juxtaposed in anticipation of ligase-mediated catalytic steps 
(Figure 2.11). In contrast, ends with helix distorting mispairs or damage near strand 
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termini – complex ends -  induce the sampling of a much wider variety of alignment 
configurations, most or all of which no longer juxtapose strand termini.  
We use a LIG4 separation of function mutation (LIG4∆i) to identify an essential 
role for this second, more dynamic “remodeling” class of PECs in cellular NHEJ for the 
repair of complex ends. We show LIG4∆i is specifically unable to accommodate PEC 
remodeling in response to complex ends. As a consequence, PECs formed with LIG4∆i 
are unable to directly ligate such substrates, but are also – with rare exception (Figure 
2.5C) – unable to couple ligation to end processing when end complexity is sufficient to 
block direct ligation.  
Notably, the exceptions are restricted to contexts where alignment-directed 
synthesis generates a fully complementary 6-nt overhang, a substrate expected to be 
especially permissive for the ligation step.   
By comparison, insert1 is dispensable for the XLF-, XRCC4-, and Ku-dependent 
alignment of ends with complementary overhangs, as well as catalytic activity on this 
conventional ligase substrate. Moreover, a chimeric ligase with all three LIG4 catalytic 
subdomains replaced with LIG3 counterparts is equally effective in ligation of “sticky” 
ends (and is similarly stimulated by Ku and XLF), but is even less able to repair complex 
ends. Prior work emphasized the importance of a variety of NHEJ proteins, including 
PAXX103,104, end processing factors33,67,72, and especially the end-bridging filament of 
XRCC4-XLF59,105,106 in repairing complex breaks. Indeed, we previously reported that 
these filaments form on bleomycin-induced DSBs and orchestrate their repair51. Here 
we identify a critical role for specialization of LIG4 catalytic subdomains in repair of 
complex ends, and show this role is attributable to insert1-dependent PEC remodeling. 
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How does insert1 contribute to PEC remodeling? The three subdomains of 
eukaryotic ligases are extended in the absence of DNA (“open” conformation), and 
engage substrates by forming a ring around double stranded DNA (“closed” 
conformation)55–57. In the closed conformation, the central catalytic subdomain is bound 
to strand break termini while insert1 is located in the N-terminal subdomain on the 
opposite side of the double helix95. Though not resolved in current apo-enzyme crystal 
structures, its location suggests that insert1 helps LIG4 maintain a closed conformation, 
either by stabilizing the ring-closing interactions between N and C terminal catalytic 
subdomains or by interacting with DNA107. We suggest stable end-pairing is dependent 
on LIG4 maintaining a closed conformation, even if LIG4 can directly interact with only 
the 5’ phosphate side of a strand break (“half-site” binding). LIG4∆i instead transitions to 
an open conformation in this context (like conventional ligases), which leads to failure of 
end pairing. 
Significance of LIG4 sensing complex ends 
Prior work indicates that LIG4 has functions in NHEJ distinct from the ligation 
step, most clearly in promoting end pairing51,93,108–110. Data presented here identify a 
much more sophisticated function. Differences in how LIG4 catalytic domains interact 
with different end structures trigger dramatic changes in the dynamics of the entire 
paired-end complex – i.e. including Ku, XRCC4, and XLF paired ends – and these 
altered dynamics determine the steps taken to complete repair. This role is distinct from 
critical LIG4 roles in catalysis and end pairing, since both of the latter functions are fully 
intact in PECs formed with LIG4∆i. LIG4 can thus be identified as the PEC “sensor,” 
helping tailor the path to repair as is appropriate to end structure, possibly even to the 
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extent that how LIG4 interacts with aligned ends may dictate the identity of the end 
processing factor that next engages the end.  
Inhibitors of LIG4 are being explored for their potential to sensitize tumors to 
radiation therapy111. Here we identify a role of LIG4 that is specific to the ability of cells 
to repair complex damage, identify a structural element required for this role, then show 
deletion of this element leads to cellular sensitivity to ionizing radiation. Since this 
structural element is unique to LIG4 and required for radioresistance, it presents a 
promising therapeutic target, as it is less likely to engender the off-target effects 
observed with current LIG4 inhibitors112. 
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Figure 2.1: Effect of LIG4 insert1 on NHEJ of complex ends in vitro  
 
(A) Structure of human LIG1 bound to DNA (1X9N; green), with inset emphasizing 
sequence and structural alignments of human LIG1 α helices 5-6 to human LIG3 (3L2P; 
blue) and human LIG4 (based on 3W1B; pink), with sequence and a modeled location 
of LIG4 insert1 (disordered in the 3W1B apoenzyme) in red. (B) Ku, XLF, and either 
XRCC4-LIG4WT (gray) or XRCC4-LIG4Δi (orange) were incubated with substrates 
containing different complementary (5’ G:C, 3’ G:C) or non-complementary (5’ GoxC, 3’ 
GxT, 3’ GxA) overhangs as noted. Joining efficiency is expressed as a fraction of the 
total junctions recovered using the 5’ G:C substrate with NHEJ reactions containing 
LIG4WT. Ligation reactions were performed in triplicate and the mean joining efficiencies 
are shown, along with the fold difference between LIG4WT and LIG4Δi for each substrate. 
Error bars represent the range of observed values for each set of experiments. 
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Figure 2.2: Biochemical Characterization of LIG4 variants 
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Figure 2.2: Biochemical Characterization of LIG4 variants 
 
(A) Amino acid sequence alignment of LIG4 orthologs, with insert1 in orange. (B) A 
nicked, Cy5-labeled 41 bp substrate was incubated with XRCC4-LIG4WT or XRCC4-
LIG4Δi in triplicate and joining was assessed by stand-denaturing gel electrophoresis. 
Error bars represent standard error of the mean for 3 experiments. The mean for LIG4Δi 
was assessed by t-test as not statistically significantly different (ns) from control 
(LIG4WT). (C) A 15 bp Cy5-labeled substrate was incubated with XRCC4-LIG4WT or 
XRCC4-LIG4Δi and substrate binding was assessed by native gel electrophoresis. (D) A 
60 bp Cy5 labeled substrate was incubated with indicated NHEJ factors and NHEJ 
complex formation was assessed by native gel electrophoresis. (E) LIG3+4 chimera was 
generated by fusing catalytic domains of LIG3 with C-terminal domains of LIG4 and 
purified after co-expression with XRCC4. NHEJ reactions were performed in vitro as in 
Figure 2.1B using undamaged (5’ G:C) and damaged (5’ GoxC) substrates. Joining 
efficiency is expressed as a fraction of the total junctions recovered using the 5’ G:C 
substrate with LIG4WT. Ligation reactions were performed in triplicate and error bars 
represent the range of observed data points. 
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Figure 2.3: Effect of complex end structures on pairing dynamics of single 
molecule complexes with LIG4WT or LIG4Δi  
 
(A) smFRET NHEJ assay: (1) dsDNA with a Cy5 acceptor is tethered to a bitonylated 
PEG surface via a biotin-neutravadin linkage, (2) dsDNA with a Cy3 donor and NHEJ 
proteins (green) are added to the chamber, and (3) ends are paired and FRET is 
observed. (B) Quantitation of pairing efficiency of ends with complementary (G:C) or 
mismatched (GxT, GxA) overhangs by Ku, XLF, XRCC4 and either LIG4WT (gray) or 
LIG4Δi (orange). Error bars represent standard error of the mean for 3 experiments. 
Means were assessed by two-way ANOVA as significantly different from control 
(LIG4WT on G:C substrate) with confidence p<0.001 (***). (C) Histograms of observed 
EFRET for PECs formed as in (B).  (D) Representative smFRET trajectory for LIG4WT and 
LIG4Δi PECs formed with GxT ends demonstrating altered transition frequency and 
FRET states (E) LIG4WT enables PECs to oscillate between high and low EFRET states in 
response to distortions, and this flexibility is essential for joining distorted breaks. 
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Figure 2.4: Effect of distorted ends on pairing dynamics of single molecule 
complexes with LIG4WT or LIG4Δi 
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Figure 2.4: Effect of distorted ends on pairing dynamics of single molecule 
complexes with LIG4WT or LIG4Δi 
 
(A) Full width at half maximum (FWHM) of peaks was calculated from EFRET histograms 
for G:C, GxT, and GxA substrates. For (A) and (C), error bars represent standard error 
of the mean for 3 experiments, and means were assessed for significance as in Figure 
2.3B with confidence p<0.01 (**), p<0.001 (***) or not significantly different (ns). (B) 
Autocorrelation of individual FRET trajectories was used to calculate average transition 
times () between FRET states of PECs formed on the GxT substrate with LIG4WT or 
LIG4Δi. (C) Transition energy between FRET states calculated from autocorrelation. (D) 
Representative smFRET trajectory for LIG4WT and LIG4Δi PECs  formed with G:C 
complementary ends (E) Representative smFRET trajectories of LIG4WT and LIG4Δi 
PECs formed with GxA ends. 
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Figure 2.5: Effect of LIG4 insert1 on cellular joining of complex end structures 
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Figure 2.5: Effect of LIG4 insert1 on cellular joining of complex end structures  
 
(A) Cells were engineered to express LIG4Δi from the native LIG4 locus by 
CRISPR/Cas9-based gene targeting, then the LIG4Δi-a clone was reverted back to wild-
type (LIG4+r/+r) by a second round of gene targeting (B-E) Substrates with varied end 
structures were introduced in the cell types described in (A). Joining efficiency was 
assessed by qPCR, and product structure by sequencing or diagnostic restriction 
digestion and defined as directly ligated or ligated after end processing as noted. 
Cellular NHEJ was assessed for (B) complementary ends, (C) ends with 3’ G:T terminal 
mismatches, (D) ends with 5’ terminal 8-oxoguanine (Go; product structures reported in 
Figure 2.6D), and (E) ends with fully non-complementary overhangs (product structures 
reported in Figure 2.6E). Error bars represent the standard error of the mean for 3 
experiments. Means of linearized qPCR data and direct joining products were assessed 
by one-way ANOVA as significantly different from control (LIG4+/+ cells) with confidence 
p<0.001 (***) or not significantly different (ns). 
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Figure 2.6: Effect of LIG4 insert1 on cellular joining of complex ends 
 
(A) Sequences of targeted region of genomic DNA harvested from LIG4+/+, LIG4Δi/Δi, 
and LIG4+r/+r cells. (B) Western blot was performed to validate similar LIG4 expression 
in the indicated cell lines (C-E) Substrates with varied end structures were introduced in 
the noted cell types. (C) G:A mispaired overhangs was electroporated into cells. Repair 
efficiency was quantified by qPCR and repair product structures were determined by 
sequencing. Product structures were classified as directly repaired (orange), gap fill-in 
synthesis (gray), or other processing (white) (D) A substrate with radiomimetic terminal 
8-oxoguanine damage was electroporated into cells. Repair product structures were 
chacterized by diagnostic restriction digests and classified as either directly ligated 
(orange) or ligated after end processing (white) (E) A substrate with fully mispaired 
TTTT overhangs was electroporated into cells. Repair product structures were 
characterized by sequencing and classified as either directly repaired (orange) or 
processed (white). Error bars for (C-E) represent standard error of the mean for 3 
experiments. Means were assessed for significance as in Figure 2.5B-E with confidence 
p<0.05 (*), p<0.001 (***) or not significantly different (ns). 
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Figure 2.7: Effect of PEC flexibility on nucleolytic end processing 
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Figure 2.7: Effect of PEC flexibility on nucleolytic end processing 
 
(A) A substrate was designed with embedded complementarity (EC1) that can be 
aligned in a high-FRET conformation guided by base pairing (a presumptive nuclease 
substrate) or in a low-FRET conformation with juxtaposition of 5’ and 3’ termini.  (B) 
Representative smFRET trajectories for transient (short lived; <30sec) and persistent 
(long lived; 30+ sec) PECs formed with the EC1 substrate (C) Histograms of EFRET of 
transient (top) or persistent (bottom) LIG4WT PECs formed on the EC1 substrate (black), 
compared to FRET standards with complementary overhangs either 4 nt (blue) or 10 nt 
(green) in length (D) Quantitation of pairing efficiency of EC1 substrate by LIG4WT (gray) 
or LIG4Δi (orange). Error bars represent standard error of the mean for 3 experiments. 
Means were assessed for significance as in Figure 2.3B with confidence p<0.001 (***) 
or not significantly different (ns). (E) The EC1 substrate was transfected into cells and 
repair efficiency was quantitated by qPCR. Error bars represent standard error of the 
mean for 3 experiments. Linearized means were assessed for significance as in Figure 
2.5B-E with confidence p<0.01 (**), p<0.001 (***) or not significantly different (ns). 
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Figure 2.8: Effect of PEC flexibility on nucleolytic end processing  
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Figure 2.8: Effect of PEC flexibility on nucleolytic end processing  
 
(A) Histogram of EFRET of PECs formed with FRET standards containing fully 
complementary overhangs either 4 nt (blue) or 10 nt (green) in length (B) Transition 
energies calculated for 4nt complementary and EC1 substrates with LIG4WT. Error bars 
represent standard error of the mean for 3 experiments. The mean energy for the EC1 
substrate was assessed by t-test as significantly different from control (4nt 
complementary) with confidence p<0.05 (*). (C) Quantitation of pairing efficiency of a 
substrate where embedded complementarity was reduced and relocated (EC2), relative 
to 4 nt complementary overhangs. Error bars represent standard error of the mean for 3 
experiments. Means were assessed by one-way ANOVA as significantly different from 
control (4nt complementary) with confidence p<0.001 (***). (D) Histograms of EFRET of 
PECs formed on the EC1 (top) and EC2 (bottom) substrates (black), compared to FRET 
standards with complementary overhangs either 4 nt (blue) or 10 nt (green) in length (E) 
Histograms of EFRET of PECs formed with LIG4Δi on the EC1 substrate (orange), 
compared to FRET standards with complementary overhangs either 4 nt (blue) or 10 nt 
(green) in length (F) The EC1 substrate was electroporated into cells. Repair product 
structures were determined by sequencing and classified as either deletion guided by 
embedded complementarity (blue), other deletions limited to single stranded overhang 
(red), or deletions that extended into double stranded flanking DNA (green).
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Figure 2.9: Effect of LIG4 insert1 on cellular sensitivity to ionizing radiation  
 
Cells were exposed to indicated doses of X-rays and assessed for colony formation. 
Data represents the mean and standard deviation of 3 experiments. Mean surviving 
fractions  were assessed by one-way ANOVA as significantly different from control 
(LIG4+/+ cells) independently for each dose with confidence p<0.05 (*), p<0.01 (**) or not 
significantly different (ns). 
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Figure 2.10: Sensitivity of LIG4 cell lines to damaging agents 
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Figure 2.10: Sensitivity of LIG4 cell lines to damaging agents 
 
(A-C) Cell growth was assessed by live cell imaging every 4 hours for 5 days after 
seeding cultures. Cells were either (A) left untreated, (B) irradiated with 4 Gy X-rays, or 
(C) treated with 200 nM etoposide. Mean growth after 5 days was assessed by one-way 
ANOVA as significantly different from control (LIG4+/+ cells) with confidence p<0.001 
(***) or not significantly different (ns). For all live cell imaging experiments, error bars 
represent the standard deviation of a triplicate.
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Figure 2.11: Sensing of differences in end structure by LIG4 guides repair  
 
Model for LIG4-dependent remodeling of paired end complexes in response to complex 
ends.  
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Substrate Construction Oligonucleotides 
Core 
CAAGTGGTCTCAGACTGGCTACCCTGCTTCTTTGAGCATTTCTGAAACTATCACTTGTGTTTATT
ATTACACTGGCATTCATTCTCCAGAGAACATGTCTAGCCTATTCCCAGCTTTGCTTACGGAGTTA
CTCTGTATCTTTGCCTTGGAGAGTGCCAGAATCTGGTTTCAGAGTAAGATTTTATACATCATTTT
TAGACATAGAAGCCACAGACATAGACAACGGAAGAAAGAGACTTTGGATTCTACTTACGTTTGAT
TTCCCTGACGGAGACCTCGGC 
5’ G:C Left Cap Top Strand GATCCTCACACCCATCTCA 
5’ G:C Left Cap Bottom Strand /5PHOS/AGTCTGAGATGGGTGTGAG 
5’ G:C Right Cap Top Strand GATCCTCGCTTAGCTGTATA 
5’ G:C Right Cap Bottom Strand /5PHOS/TGACTATACAGCTAAGCGAC 
5’ GoxC Left Cap Top Strand GOATCCTCACACCCATCTCA 
5’ GoxC Left Cap Bottom Strand /5PHOS/AGTCTGAGATGGGTGTGAG 
5’ GoxC Right Cap Top Strand GOATCCTCGCTTAGCTGTATA 
5’ GoxC Right Cap Bottom Strand /5PHOS/TGACTATACAGCTAAGCGAC 
3’ G:C Left Cap Top Strand /5PHOS/AGTCTGAGATGGGTGTGCGGCGCG 
3’ G:C Left Cap Bottom Strand CCGCACACCCATCTCA 
3’ G:C Right Cap Top Strand /5PHOS/TGACTATACAGCTAAGCGGCGCG 
3’ G:C Right Cap Bottom Strand CCGCTTAGCTGTATA 
3’ GxT Left Cap Top Strand /5PHOS/AGTCTGAGATGGGTGTGCTGTGCG 
3’ GxT Left Cap Bottom Strand CAGCACACCCATCTCA 
3’ GxT Right Cap Top Strand /5PHOS/TGACTATACAGCTAAGCTGTGCG 
3’ GxT Right Cap Bottom Strand CAGCTTAGCTGTATA 
3’ GxA Left Cap Top Strand /5PHOS/AGTCTGAGATGGGTGTGCAGAGCG 
3’ GxA Left Cap Bottom Strand CTGCACACCCATCTCA 
3’ GxA Right Cap Top Strand /5PHOS/TGACTATACAGCTAAGCAGAGCG 
3’ GxA Right Cap Bottom Strand CTGCTTAGCTGTATA 
3’ TTTT Left Cap Top Strand /5PHOS/AGTCTGAGATGGGTGTGCTGTTTT 
3’ TTTT Left Cap Bottom Strand CAGCACACCCATCTCA 
3’ TTTT Right Cap Top Strand /5PHOS/TGACTATACAGCTAAGCTGTTTT 
3’ TTTT Right Cap Bottom Strand CAGCTTAGCTGTATA 
EC1 Left Cap Top Strand /5PHOS/AGTCTGAGATGGGTGTGTTTGTGCTTTTTT 
EC1 Left Cap Bottom Strand AAACACACCCATCTCA 
EC1 Right Cap Top Strand /5PHOS/TGACTATACAGCTAAGCGTGCACTTTTTT 
EC1 Right Cap Bottom Strand ACGCTTAGCTGTATA 
Nicked Substrate Top Strand Left 
Fragment 
/5CY5/AGAAAACTGGCCCTTGCCATT 
Nicked Substrate Top Strand Right 
Fragment 
/5PHOS/CTCGGTGAGAGCATCGCTTA 
Nicked Substrate Bottom Strand TAAGCGATGCTCTCACCGAGAATGGCAAGGGCCAGTTT
TCT 
DSB End Substrate Top Strand /5PHOS/TCACACACGCACGCATTTTT 
DSB End Substrate Bottom Strand /5CY5/TTTTTTGCGTGCGTGTGTGA 
Complex Formation Substrate Top 
Strand 
/5PHOS/CTCAGCTGGGAATTCCATATGAGTACTGCAG
ATGCACTTGCTCGATAGATCTAACATGAG 
Complex Formation Substrate 
Bottom Strand 
/5CY5/GTAGGGCTCATGTTAGATCTATCGAGCAAGTG
CATCTGCAGTACTCATATGGAATTCCCAGCTGAG 
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FRET Acceptor Top Strand /5PHOS/CGTG/ICY5/AGAGGAGACAGAGTGCGGGCG
AACAACATAAATCGTACCCTCGTATGTATCGTATGGCT
CATGCTTATCAGATGCT/3BIO/ 
FRET Acceptor Bottom Strand 
(G:C) 
AGCATCTGATAAGCATGAGCCATACGATACATACGAGG
GTACGATTTATGTTGTTCGCCCGCACTCTGTCTCCTCT
CACGCGCG 
FRET Acceptor Bottom Strand 
(GxT) 
AGCATCTGATAAGCATGAGCCATACGATACATACGAGG
GTACGATTTATGTTGTTCGCCCGCACTCTGTCTCCTCT
CACGTGCG 
FRET Acceptor Bottom Strand 
(GxA) 
AGCATCTGATAAGCATGAGCCATACGATACATACGAGG
GTACGATTTATGTTGTTCGCCCGCACTCTGTCTCCTCT
CACGAGCG 
FRET Acceptor Bottom Strand (4 nt 
comp) 
AGCATCTGATAAGCATGAGCCATACGATACATACGAGG
GTACGATTTATGTTGTTCGCCCGCACTCTGTCTCCTCT
CACGGCAC 
FRET Acceptor Bottom Strand 
(EC1) 
AGCATCTGATAAGCATGAGCCATACGATACATACGAGG
GTACGATTTATGTTGTTCGCCCGCACTCTGTCTCCTCT
CACGGCACTTTTTT 
FRET Acceptor Bottom Strand 
(EC2) 
AGCATCTGATAAGCATGAGCCATACGATACATACGAGG
GTACGATTTATGTTGTTCGCCCGCACTCTGTCTCCTCT
CACGGAATTCGCAC 
FRET Donor Bottom Strand /5PHOS/TCTG/ICY3/ATAAGCATGAGCCATACGATA
CATACGAGGGTACGATTTATGTTGTTCGCCCGCACTCT
GTCTCCTCTCACGTTTTCGTGAGAGGAGACAGAGTGC 
FRET Donor Top Strand (G:C) GGGCGAACAACATAAATCGTACCCTCGTATGTATCGTA
TGGCTCATGCTTATCAGACGCG 
FRET Donor Top Strand (GxT) GGGCGAACAACATAAATCGTACCCTCGTATGTATCGTA
TGGCTCATGCTTATCAGATGCG 
FRET Donor Top Strand (GxA) GGGCGAACAACATAAATCGTACCCTCGTATGTATCGTA
TGGCTCATGCTTATCAGAAGCG 
FRET Donor Top Strand (4 nt 
comp) 
GGGCGAACAACATAAATCGTACCCTCGTATGTATCGTA
TGGCTCATGCTTATCAGAGTGC 
FRET Donor Top Strand (10 nt 
comp) 
GGGCGAACAACATAAATCGTACCCTCGTATGTATCGTA
TGGCTCATGCTTATCAGAGTGCGAATTC 
FRET Donor Top Strand (EC1) GGGCGAACAACATAAATCGTACCCTCGTATGTATCGTA
TGGCTCATGCTTATCAGAGTGCTTTTTT 
FRET Donor Top Strand (EC2) GGGCGAACAACATAAATCGTACCCTCGTATGTATCGTA
TGGCTCATGCTTATCAGATTTTTTTTTT 
 
PCR Primer Oligonucleotides 
qPCR NHEJ Assay Forward CTTACGTTTGATTTCCCTGACTATACAG 
qPCR NHEJ Assay Reverse GCAGGGTAGCCAGTCTGAGATG 
Illumina Amplification Forward NNNNNNCTTACGTTTGATTTCCCTGACTATACAG 
Illumina Amplification Reverse NNNNNNGCAGGGTAGCCAGTCTGAGATG 
Illumina Adapter Top Strand /5PHOS/GATCGGAAGAGCGGTTCAGCAGGAATGCCGA
G 
Illumina Adapter Bottom Strand ACACTCTTTCCCTACACGACGCTCTTCCGATCT 
Illumina Enrichment Forward AATGATACGGCGACCACCGAGATCTACACTCTTTCCCT
ACACGACGCTCTTCCGATCT 
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Illumina Enrichment Reverse CAAGCAGAAGACGGCATACGAGATCGGTCTCGGCATTC
CTGCTGAACCGCTCTTCCGATCT 
CRISPR Screening Forward TGAGTTGGAATCGAATGCTG 
CRISPR Screening Reverse GAGGGGGCTTCTCTGCTACT 
GoxC Amplification Forward /5CY5/CCTTGGAGAGTGCCAGAATC 
GoxC Amplification Reverse CTGGAGAATGAATGCCAGTG 
 
Oligonucleotides to generate sgRNAs (guide italicized and underlined) 
Target LIG4WT Top Strand ccggGCATCTCCATGAGTTCCAGT 
Target LIG4WT Bottom Strand aaacACTGGAACTCATGGAGATGC 
Target LIG4Δi Top Strand ccggACTTTTAAACTACGAACAAG 
Target LIG4Δi Bottom Strand aaacCTTGTTCGTAGTTTAAAAGT 
 
Gene Targeting Regions 
LIG4WT and LIG4+r/+r sequence (guide italicized and underlined; BpmI site bolded) 
AAACTTTTAAACTACAGAACACCCACTGGAACTCATGGAGATGCTGGAGACTTTGC 
LIG4Δi sequence (guide italicized and underlined; BsmFI site bolded) 
AAACTTTTAAACTACGAACAA------------------------GGGGACTTTGC 
 
Table 2.1: Sequences of DNA Reagents 
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CHAPTER 3: RIBONUCLEOTIDES ENABLE FLEXIBILITY IN NHEJ 
 
 
3.1 Introduction 
Nonhomologous end joining (NHEJ) is the primary pathway for repairing 
chromosomal double-strand breaks (DSBs) in mammals, and is required for genome 
stability in all cell types as well as assembly of antigen specific receptors by V(D)J 
recombination in lymphocytes113. NHEJ employs specialized nucleases and 
polymerases, including the widely-expressed Pol µ (gene name, Polm) and lymphocyte-
specific terminal deoxynucleotidyl transferase (TdT), to modify broken end structures in 
preparation for ligation4. Accordingly, loss of Pol µ or TdT interferes with normal cell 
growth, resistance to DNA damage, and development of robust immune 
responses14,72,80,81,114–116. Pol µ and TdT are exceptionally poor at discriminating against 
ribonucleotide incorporation in vitro37,87–90, favoring deoxynucleotides 1.4 to 11-fold 
(depending on nucleotide base) more than ribonucleotides88. By comparison, closely 
related Pol λ and Pol β incorporate deoxynucleotides several 1000-fold more efficiently 
than ribonucleotides83–85 (similar to most other polymerases that maintain DNA 
genomes).  However, it is unknown whether ribonucleotide incorporation occurs during 
cellular NHEJ, and if ribonucleotide incorporation occurs, if it significantly impacts NHEJ 
function.  
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3.2 Methods 
Cell Lines 
WT (C57BL/6) or Polm-/- murine fibroblast cells (generously provided by Dr. L. 
Blanco) were derived from E14.5-d embryos and immortalized by the introduction of SV-
40 large T-antigen as described previously117. The ts-AbMLV pre-B cells were a 
generous gift from Dr. Y. Chang (Arizona State University). These lines and variants 
described below were confirmed to be free of mycoplasma contamination by PCR118; 
cell lines were additionally selected at random for third party validation of PCR results 
using Hoechst staining119. Variants of MEFs and pre-B cell lines with frameshift 
mutations in Exon 2 of the Rnaseh2a gene or Exon 1 of the Polm gene were generated 
by transient expression of nickase Cas9 D10A and a pair sgRNAs (Table 3.3). Cell lines 
were engineered to express either Myc-tagged Pol µ or TdT by infection with retrovirus 
derived from pBabe-puro constructs containing the appropriate murine cDNAs. All cell 
lines were sub cloned by limiting dilution and verified by western blot analysis and allele 
sequencing (where applicable). Wild-type and LIG4-deficient HCT116 cells were a gift 
from Dr. Eric Hendrickson. Western blots were performed using standard techniques 
and antibodies against murine RNaseH2A (ProSci, 4979), Actin (Sigma, A2066), TdT 
(Sigma, 14.9739.80), or the Myc affinity tag (Santa Cruz, sc409E10). MEF and HCT116 
cells were maintained in DMEM supplemented with 10% (vol/vol) FBS (Sigma), 5 mM 
N-acetyl-L-cysteine (Sigma), 2 mM L-glutamine (Gibco), 100U/ml penicillin, and (in 
variant lines expressing puromycin resistance markers) 2 μg/mL puromycin, at 37°C 
and 5% CO2. The ts-AbMLV cell lines were maintained in RPMI 1640 (Corning) 
supplemented with 10% (vol/vol) FBS (Sigma), 2 mM L-glutamine (Gibco), 55 μM 2-
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mercaptoethanol (Gibco), 100U/ml penicillin, and (in variant lines expressing puromycin 
resistance markers) 2 μg/mL puromycin, at 33°C and 5% CO2.  Recombination in SP9 
cells was induced by culture at 40°C. 
Double strand break repair assays 
Substrates described in Figure 3.1 were generated by PCR amplification of a 
common 280-bp DNA segment with primer pairs containing embedded restriction 
enzyme digest sites chosen to generate the desired end structures (Table 3.3). 
Substrates were digested, purified by agarose gel electrophoresis, and purified 
substrate recovered using the QiaQuick gel-extraction kit (Qiagen). Substrates 
described in Figure 3.7 were assembled by ligation of ~15 bp double-stranded DNA 
caps (oligonucleotide pairs annealed to generate gaps in Table 3.3) containing the 
desired overhang sequence to a 280 bp core fragment digested with BsaI-HF (New 
England Biolabs), with the caps in 3 fold excess. Substrates were then purified using a 
QiaQuick PCR purification kit (Qiagen), and resolved on a native acrylamide gel to 
ensure substrates preparations were free of detectable unappended core and excess 
cap.  
Extrachromosomal substrate electroporations were carried out using the NEON 
transfection system (Invitrogen) with 20 ng of substrate, 600 ng pMAX-GFP carrier 
plasmid, and 2 × 105 cells by a 1350 V, 30 ms pulse in a 10 μl chamber. Following 
transfection, cells were incubated at 37°C in HBSS (Gibco) supplemented with 1 mM 
MgCl2 and Benzonase Nuclease (Sigma) for the indicated amount of time. Cellular DNA 
was harvested using a QiaAmp DNA mini kit (Qiagen). Rosa26 locus-targeting Cas9 
ribonucleoproteins (RNPs) were assembled from purified Cas9 (derived from Addgene 
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#69090), and annealed Alt-R modified crRNA (Table S2) and trcrRNA (IDT).  The Cas9-
sgRosa26 RNP complex was introduced at 1.8 μM into 2×106 cells and a 100 uL 
chamber using a 1350 V, 30 ms pulse and incubated at 37°C before cell harvesting and 
purification of genomic DNA (QiaAmp DNA mini kit). For experiments involving 
nucleotide electroporation into cells, the transfection mixture was supplemented with 
either 10 mM NaCl, 10 mM rGTP, or 10 mM dGTP. 
In vitro NHEJ assays were performed initiated by incubating 2 nM DSB 
substrates with either NHEJ proteins (25 nM Ku, 40 nM XLF, and 40 nM XRCC4-LIG4) 
or 160 units of T4 DNA ligase (New England Biolabs) in a buffer with 25 mM Tris pH 
7.5, 100 uM EDTA, 1 mM DTT, 1 mM MgCl, 100 uM ATP, 150 mM KCl, 7.5% 
polyethelene glycol 3000, and 100 ng of supercoiled plasmid DNA. Reactions were 
carried out for 10 minutes at 37 C and stopped with 0.1% SDS and 20 mM EDTA.  
Repair product analysis 
Recovery of joined products was quantified by real-time PCR (qPCR) using a 
QuantStudio 6 System (Applied Biosystems), primers that amplify head-to-tail junctions 
(Table 3.3), and VeriQuest Probe qPCR Master Mix (Affymetrix). We validated our 
assays as efficient, reproducible, and linear over the range relevant to these 
experiments (Figures 3.2A, 3.2B, 3.5A, 3.6A). The fraction of products with embedded 
ribonucleotides (%ribo.) was measured by comparison of samples digested with 2.5 
units of RNaseHII (New England Biolabs) at 37 C for 16 hours in the manufacturer’s 
provided buffer to mock treated samples; these conditions were sufficient to cleave to 
completion sites of embedded ribonucleotides regardless of opposite strand structure, 
with no obvious digestion of DNA-only controls. Restriction enzymes that cut outside the 
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amplicons (NlaIII and MseI for Rosa26 samples, and HaeIII and MseI for substrate 
samples) were also included in RNaseHII and mock treated samples to ensure the initial 
denaturation of template duplexes occurred with equal efficiency. As an alternative 
method of ribonucleotide cleavage, samples were treated with 300 mM NaOH for 2 
hours at 55 ºC (or mock treated with 300 mM NaCl) and neutralized by a 10x dilution 
into 65 mM Tris-HCl buffer (pH 8.0; Figure 3.3A). For Figures 3.1E, 3.7A, and 3.7B, 
products were amplified with a Cy5-labelled primer and amplified products further 
characterized by digestion with restriction enzymes diagnostic for specific products 
(Table 3.1; NsiI for G3’ and CG3’, SalI for CAG3’, AatII for CGCAG3’, and FspI for 
TTTTTTTTGC3’). Digestion products were resolved on a 5% non-denaturing 
polyacrylamide gel, visualized using a Typhoon Imager (GE Healthcare), and quantified 
using ImageJ software. 
Mutations in CRISPR-Cas9 products were assessed by amplifying the targeted 
locus and either by restriction digesting the non-mutated products with XbaI, or by 
sanger sequencing and Tracking of Indels by DEcomposition (TIDE)120. 
Next-generation Sequencing 
Template DNA for each sequencing library (~5 × 105 input molecules) was 
amplified using Phusion DNA polymerase (New England Biolabs) and PCR primers with 
six-nucleotide index sequences appended to their 5′-ends (Table 3.3). Amplified DNA 
was 5′phosphorylated with T4 Polynucleotide kinase then treated with Klenow exo- to 
add dA to the 3′ termini (New England Biolabs). Sequencing adapters for paired-end 
reads were appended to the amplicons by treatment with T4 DNA ligase, and free 
adapter removed by agarose gel purification. After a final enrichment PCR amplification 
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the products were purified by Agencourt AMPure XP beads (Beckman Coulter). 
Libraries were submitted for a 2 × 150-bp sequencing run (MiSeq; Illumina) with a 
PhiX174 DNA “spike”. Data analysis with Genomics workbench v7.5.1 (CLC-Bio) and 
Microsoft Excel was carried out as described72. 
 
3.3 Results 
Cellular NHEJ products contain ribonucleotides 
We initially investigated whether ribonucleotides are incorporated during NHEJ of 
a linear DNA substrate introduced into transformed mouse embryonic fibroblasts 
(MEFs; Figure 3.1A). We optimized this assay to allow for rapid harvesting of repair 
products, in anticipation that ribonucleotides were only transiently present, and 
employed qPCR to quantify products with embedded ribonucleotides (Figure 3.2A-C). 
Embedded ribonucleotides were present in 60% (standard deviation = sd; 4.2%) of 
NHEJ products (Figure 3.1B) when products were assessed within the first minute, and 
were dependent on either Pol µ or TdT (Figure 3.1C and Figure 3.2D-E). 
The fraction of NHEJ products with embedded ribonucleotides decayed until 
ribonucleotides were undetectable after 20 minutes (Figure 3.1B, black line). To 
determine if this reduction was due to replacement of incorporated ribonucleotides with 
deoxynucleotides (Ribonucleotide excision repair; RER), we generated a MEF variant 
deficient in Rnaseh2a (Figure 3.2F), which initiates RER86. Levels of embedded 
ribonucleotides were initially similar in Rnaseh2a-deficient cells, before stabilization at 
levels approximately two-fold less than was initially observed (Figure 3.1B, orange line).  
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The substrate used above possessed a single nucleotide 3’ overhang (3’G). Pol 
µ-dependent addition of a complementary C (+C product) accounts for approximately 
half of repair of this substrate72 (Figure 3.1D-E, Figure 3.3), while remaining products 
have heterogeneous 1-5 bp deletions of flanking sequence and variable dependency on 
Pol µ activity72. To focus on Pol µ-dependent NHEJ, we digested products with a 
restriction enzyme specific for the +C product (NsiI; Figure 3.1D).  Embedded 
ribonucleotides were present in 91% (sd 8%) of NsiI-sensitive products after 1 minute 
(Figure 3.1E). Similar results were observed when using a different method to detect 
ribonucleotide-containing products (Figure 3.3A). Moreover, embedded ribonucleotides 
were only modestly less frequent (75%, sd 8) using a substrate with a different 
overhang template (C3’) and Pol µ-dependent added nucleotide (+G product; Figure 
3.3B). Importantly, our ability to detect repair products (and thus %RNA) is fully 
dependent on NHEJ, as LIG4-deficient cells show 330-fold defective repair (Figure 
3.3C). We conclude most Pol µ and TdT-dependent NHEJ products contain embedded 
ribonucleotides, and that the modest preference of these polymerases for addition of 
deoxynucleotides in vitro88 is overwhelmed by higher concentrations of ribonucleotides 
in cells121. 
As also informed by data presented in subsequent figures, we suggest these 
early products involve one ligated strand only. Subsequent repair of the complementary 
strand with deoxynucleotides accounts for the two-fold dilution of products with 
embedded ribonucleotides that is independent of Rnaseh2a (Figure 3.1B, orange line), 
while complete removal of ribonucleotides requires Rnaseh2a-dependent ribonucleotide 
excision repair.  
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RNA is integrated into the genome during chromosome break repair 
We determined if ribonucleotides are similarly incorporated during repair of 
breaks in the chromosome by NHEJ. We used a pre-B cell line (SP9) that can be 
induced to undergo V(D)J recombination at the immunoglobulin kappa locus (Igk; Figure 
3.4A), since Pol µ is efficiently engaged by the 3’ overhang intermediates in this 
process71,81. Embedded ribonucleotides were undetectable 24 hours after induction 
when cells were proficient in RER. By comparison, 35% of Igk recombination products 
possessed embedded ribonucleotides in an Rnaseh2a-deficient variant (Figure 3.4B 
and Figure 3.5A-B). This frequency is approximately half of the frequency of Igk 
products where Pol µ is active71,81, consistent with the model proposed above (where 
only the first strand of a chromosome double strand break is repaired with 
ribonucleotides). Embedded ribonucleotides were again largely dependent on either Pol 
µ or TdT (Figure 3.4B and Figure 3.5C-D). We additionally confirmed that V(D)J 
recombination was induced in these cell lines by qPCR across the VJK junction (Figure 
3.5E). 
We sought to assess the frequency of Polymerase-dependent ribonucleotide 
incorporation during chromosomal NHEJ shortly after repair, and also to extend analysis 
to a non-lymphoid model. Cas9-induced chromosome breaks in TdT-expressing MEFs 
(Figure 3.2E) results in a repair product - addition of two or more Gs, with no loss of 
flanking DNA (“+GG product”) –that was abundant (18% of chromosomal repair 
products, Table 3.2), unambiguously polymerase-dependent, and detectable by qPCR 
(Figure 3.4C-D and Figure 3.6A-B). Additionally, direct introduction of Rosa26 locus-
targeted Cas9 nuclease allowed for assessment of repair products immediately after 
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they were generated (Figure 3.6C). In Rnaseh2a-deficient MEFs, 84% and 77% of +GG 
NHEJ products had embedded ribonucleotides when analyzed 1 and 4 hours after 
introduction of Cas9 (Figure 3.4D). Embedded ribonucleotides were reduced two-fold in 
these RER-deficient cells over the next 20 hours, consistent with repair of 
complementary strands with deoxynucleotides. As expected, embedded ribonucleotides 
did not accumulate to high levels in cells with intact RER (23% after 1 hour; Figure 
3.6D). RNA was not detected at significant levels by amplification an in-tact genomic 
locus in RER-deficient MEFs, consistent with an expected ~3% rate of genomic 
ribonucleotides in a 100 bp amplicon in these cells, based on RER studies (Figure 
3.6E).  
Ribonucleotides enable ligation of mismatched ends 
Both Pol µ and TdT primarily incorporate ribonucleotides during cellular NHEJ, 
thus we investigated the consequences of ribonucleotide addition on the next step of 
cellular NHEJ, ligation. Variants of substrates previously associated with Pol µ and TdT 
activity were made such that polymerase-dependent nucleotide additions were already 
included, and varied such that the included nucleotide(s) terminated with a 
ribonucleotide vs. a deoxynucleotide (Figure 3.7A). We then assessed effects of 
differing termini on the NHEJ ligation step by introducing these simulated polymerase 
products into cells that express neither Pol µ nor TdT (Polm-/- MEFs). When the 
opposite strand was complementary (i.e. cohesive ends or nicks), there was little impact 
of a ribonucleotide vs. deoxynucleotide terminus on the ligation step of cellular NHEJ 
(Figure 3.7B)88,90. In contrast, a ribonucleotide terminus was 48-fold more effective in 
promoting direct ligation on a candidate product of TdT activity, where the opposite 
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strand possessed a 9-nucleotide gap (Table 3.1 and Figure 3.7B). Ribonucleotide 
termini were also 17-fold more effective in promoting direct ligation when using typical 
products of Pol µ activity72, where the opposite strand was short (2 or 4 nucleotides 
long) and largely mispaired (Table 3.1 and Figure 3.7B). By comparison, the same 
substrates with deoxynucleotide termini resulted in both less efficient repair, and more 
frequent deletion of flanking DNA in the repair products that were recovered (Table 3.1 
and Figure 3.8A-C). We also showed that ribonucleotides stimulate LIG4 activity on 
such substrates in vitro. In contrast, T4 ligase gains no benefit from a terminal 
ribonucleotide, suggesting that LIG4 is specifically suited to ligate ends with a terminal 
ribonucleotide (Figure 3.8D). The contribution of these polymerases to cellular NHEJ is 
thus largely reliant on their ability to incorporate ribonucleotides. 
We substituted the 3’ terminal ribonucleotide with different nucleotide analogs to 
clarify the chemical basis for stimulation of the NHEJ ligation step.  
Arabinofuranosylcytidine (AraC) is a stereoisomer of (ribo)cytidine (rC), differing from rC 
only with respect to orientation of the 2’OH relative to its chiral center. As a 
consequence, AraC favors a C2’ endo sugar pucker, relative to the C3’ endo sugar 
pucker favored by rC (Figure 3.8E). Significant amounts of direct ligation product were 
not detectable when employing an AraC terminus (Figure 3.8E and Table 3.1) – indeed, 
direct ligation was even less efficient than observed when using a deoxynucleotide 
terminus (which, while favoring C2’ endo, can adopt both sugar puckers; Figure 3.8E). 
Substitution of a fluorine for the 2’ OH of rC (2-FC; favors C3’ endo) led to levels of 
direct ligation similar to those observed with rC (Figure 3.8E and Table 3.1). Stimulation 
of the NHEJ ligation step by ribonucleotides is thus best attributed to the presence of a 
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C3’ endo sugar pucker in the 3’ terminal nucleotide. 
Deoxynucleotides block mutagenic repair of Cas9 breaks 
To address the biological significance of ribonucleotide-dependent NHEJ, we 
directly introduced nucleotide triphosphates into TdT-expressing cells alongside Cas9-
sgRosa26 RNP and harvested genomic DNA one hour after transfection. We initially 
assessed accumulation of the +GG product and found that adding riboguanosine 
triphosphate (rGTP) stimulates +GG recovery, while adding deoxyguanosine 
triphosphate (dGTP) impairs it 5-fold. (Figure 3.7D). These effects are attributable to the 
stimulation of direct ligation by ribonucleotides, since araGTP mimics dGTP in blocking 
+GG recovery (Figure 3.8F).  
We next used two different methods, Tracking of Indels by DEcomposition 
(TIDE)120 and simple restriction enzyme screening to assess the recovery of all Cas9-
mediated insertions and deletions, instead of focusing on a single product. In both 
cases, we found that dGTP transfection reduces the frequency of indels, while rGTP 
transfection had no significant effect (Figure 3.8G-H). The inhibitory effect of dGTP is 
restricted to insertions, and thus attributable to its incorporation by these polymerases 
(Figure 3.8H). As observed with the +GG product, araGTP has a similar effect on indel 
recovery as dGTP (Figure 3.8G-H), implying the reduction of insertion products is 
attributable to a block of the NHEJ ligation step. 
 
3.4 Discussion 
Our results argue mammalian NHEJ often requires three sequential strand-break 
repair reactions (Figure 3.7E). In the first reaction, Pol µ and TdT primarily add one or 
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more ribonucleotides to one 3’ terminus of a double strand break, which is necessary for 
efficient ligation of the first strand at end structures where these polymerases are 
uniquely active (Table 3.1). The ligase required for NHEJ (LIG4) may even be alone 
amongst mammalian ligases in the ability to take advantage of ribonucleotide termini, 
analogous to the in vitro activity of bacterial Pseodomonas LigD when compared to that 
of e.g. E. coli LigA122. 
The now-ligated, ribonucleotide-containing first strand can then be used as a 
template for a straightforward gap repair reaction of the opposite (second) strand, 
explaining the two-fold dilution of embedded ribonucleotides that is independent of 
RER/RNaseH2A. Alternative models – where ribonucleotides are incorporated in both 
strands, or if RNaseH2 incises the first strand before second strand repair is complete – 
risk re-breakage of the chromosome. Additionally, the transient nature of the 
ribonucleotide embedded intermediate (t1/2 is likely less than 5 minutes; Figure 3.1B) 
suggests that RER is directly coupled to NHEJ. Much of double strand break repair may 
thus require three distinct but coupled repair reactions, with NHEJ-specific factors 
definitively implicated only in the first. 
Pol µ is widely expressed and participates in repair of 16% of Cas9-induced blunt 
ended structures and the majority of end structures with mispaired 3’ overhangs72. In 
lymphocytes, either TdT or Pol µ is active in 65% of NHEJ events required for V(D)J 
recombination71,81,115,116. Therefore, the model proposed here – three obligatorily 
ordered strand break repair reactions, with a ribonucleotide-embedded intermediate that 
is central to flexible and efficient repair – is relevant to a large fraction of mammalian 
NHEJ. This mechanism is likely also important for NHEJ in species with polymerases 
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similarly prone to ribonucleotide incorporation (e.g. fungi and bacteria)123–125. Our work 
argues the important roles of mammalian Pol µ and TdT in promoting long term cellular 
proliferative capacity, the development of adaptive immunity, and radioresistance are 
reliant on their preference for incorporating ribonucleotides14,80,81,114. 
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Figure 3.1: Ribonucleotide incorporation during cellular NHEJ 
 
(A) DNA fragments with 3’G overhangs at ends were introduced into MEFs, and % 
cellular NHEJ products with embedded ribonucleotides (% ribo.) quantified by 
comparing amplification efficiency with and without prior cleavage at sites of 
ribonucleotide incorporation (also Fig. S1B). (B) % ribo. after introduction of substrate 
into Rnaseh2a+/+ (gray) or Rnaseh2a-/- (orange) MEFs. Data points are the mean of 3 
transfections, and error bars represent sd. (C) %ribo. in products recovered after 1 
minute. Data points are the mean of 3 transfections, and error bars represent sd. (D-E) 
Digestion of amplified products with NsiI and electrophoresis distinguishes Pol m-
dependent +C products from products with deletions of flanking sequence (Δ). (E) The 
mean % ribo. in NsiIs products recovered after 1 minute from three independent 
transfections, ± sd, is noted below gel.
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Figure 3.2: Assays and cell lines to assess ribonucleotide content during NHEJ 
 
(A) A serial dilution of an oligonucleotide model repair product from the 
extrachromosomal NHEJ assay (Fig. 1) was used as a template in a qPCR reaction. 
Mean qualification cycle from 3 independent experiments is plotted with error bars 
representing sd. (B) Model amplicons containing a single embedded ribonucleotide 
were mixed with fully DNA amplicons at known proportions, and diluted into genomic 
DNA at a target to genomic DNA ratio similar to experimental conditions. These 
mixtures were mock or RNaseHII digested before qPCR as described in methods. Mean 
detected ribonucleotides from 3 experiments is plotted with error bars representing sd. 
(C) Extrachromosomal substrate assay was performed as in Fig. 1A for the indicated 
amounts of time. Mean repair efficiency of 3 independent transfections is plotted with 
error bars representing sd. (D-F) Western blots were performed against the indicated 
affinity tag and mouse proteins (Myc, TdT, Actin or RNaseH2A) in the indicated MEF 
cell lines.  
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Figure 3.3: Detection of ribonucleotides in cellular NHEJ products 
 
(A-B) Repair products were recovered after 1 minute as in Fig. 1E. (A) %ribo. 
determined by comparison of samples treated with alkali and heat to mock treated. (B) 
%ribo. of +G product determined as in Fig. 1E. Ribonucleotide detection is shown as the 
mean ± sd of 3 independent transfections. (C) The indicated NHEJ substrate was 
introduced into cells either proficient or deficient in LIG4. Repair products were amplified 
by qPCR. All data points and the mean repair efficiency are shown. 
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Figure 3.4: Ribonucleotide incorporation during repair of chromosomal breaks  
 
(A-B) SP9 pre-B cells were induced for 24 hours, resulting in expression of RAG1+2 
nuclease and introduction of chromosome breaks adjacent to VK and JK coding 
segments (boxes). % ribo. in VJK coding junctions was measured as in Fig. 1A. (B) Data 
points are the mean of five independent inductions, and error bars represent sd. (C-D) 
Rosa26 locus-targeting Cas9 ribonucleoprotein was introduced into MEFs deficient in 
Rnaseh2a and expressing TdT. % ribo. was detected as in Fig. 1A using a qPCR 
specific for the TdT-dependent +GG product (also Fig. S4). (D) Data points are the 
mean of 3 independent transfections, and error bars represent sd.  
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Figure 3.5: Detecting ribonucleotides in V(D)J recombination 
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Figure 3.5: Detecting ribonucleotides in V(D)J recombination 
 
(A) A model amplicon of V(D)J recombination products at the murine VK locus was 
amplified by qPCR. Data represent the mean quantitation cycle (Cq) from 3 
independent experiments and error bars represent the sd. (B-D) Western blots were 
performed against the indicated affinity tag and murine proteins (Myc, TdT, Actin or 
RNaseH2A) in the indicated SP9 cell lines. (E) V(D)J recombination was induced for 24 
hours in SP9 pre-B cells of the indicated genotypes and induction was measured by 
qPCR across the VJK junction. All data points and the mean induction level are shown. 
Experiments were compared to the wild type parental line by ANOVA with p values 
corrected for multiple comparisons, and are reported as ns (no significant difference 
from wild type parental line), or * (significantly different from parental line, p<0.05). 
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Figure 3.6: Ribo-NHEJ facilitates genome engineering. 
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Figure 3.6: Ribo-NHEJ facilitates genome engineering. 
 
(A) A serial dilution of a model amplicon of the TdT-dependent +GG repair CRISPR 
repair product was used as a template for qPCR. Data represent the mean Cq from 3 
independent experiments and error bars represent the sd. (B-E) CRISPR break repair 
assay was performed as described in Fig. 2C and (B) +GG repair products were 
assessed 0 or 72 hours after introduction of Cas9 RNP, with or without TdT expression. 
Results from each of triplicate transfections are shown, and error bars represent the sd 
from the mean. (C) Accumulation of +GG repair products over the indicated amounts of 
time using TDT-expressing RnaseH2a-/- MEF cells. Mean product recovery efficiency, 
relative to 72 hours, for 3 independent transfections is plotted with error bars 
representing sd. (D) %ribo. in +GG products recovered after 1 hour from TDT-
expressing MEF cells either proficient or deficient in Rnaseh2a. (E) %ribo. detected at 
an uncut genomic control locus or in +GG products as in Fig. 2D. (D-E) Data represent 
the mean ribonucleotide detection in 3 independent experiments and error bars 
represent the sd. 
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Figure 3.7: Impact of ribonucleotide termini on the NHEJ ligation step 
 
(A-B) Termini of NHEJ substrates were varied to be consistent with polymerase-
dependent addition of a ribonucleotide vs. a deoxonucleotide, and introduced into Polm-
/- MEFs. Sensitivity of amplified products to a diagnostic restriction enzyme (RE) was 
used to identify examples of direct head-to-tail ligation. (B) The mean % directly ligated 
products for three independent transfections, ± sd, is noted below. (C) Substrates with 
terminal nucleotides varied to have dC, rC, araC, or FC were introduced into Polm-/- 
MEFs, and directly ligated products quantified as in Fig. 3A-B. (D) Deoxy- or ribo-
guanine triphosphate were added to Rosa26 Cas9-sgRNP transfections performed as in 
Fig. 2C-D, and genomic DNA was harvested after 1 hour. Data are the mean +GG 
recovery from 4 transfections and error bars are standard deviations. (E) Triple strand 
break repair model. 
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Figure 3.8: Ribonucleotides enable direct ligation of complex end structures. 
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Figure 3.8: Ribonucleotides enable direct ligation of complex end structures. 
 
(A-B) Substrates with complex ends and either a terminal ribonucleotide or 
deoxynucleotide were introduced into polymerase-deficient MEF cells and repair 
product structures were analyzed by high throughput sequencing. (A) Repair products 
were categorized as either directly joined (orange) or deletion products (gray). The area 
of the rC pie graph was made proportional to the mean joining efficiency for this 
substrate relative to the joining efficiency for the dC substrate, as determined by qPCR. 
(B) The deletion size was determined for each recovered product and averaged for rC 
vs. dC substrates. Data represent the means of three independent experiments, and 
error bars represent sd. (C) Indicated substrates were introduced into MEF cells as in 
Table 1. The total amount of substrate introduced into cells was quantified by qPCR. 
Data represent the means of 3 independent transfections and error bars represent s.d. 
(D) in vitro ligation reactions were performed on the indicated substrate using either 
NHEJ proteins (Ku, XLF, XRCC4, LIG4) or T4 DNA ligase. Ligation was quantified by 
qPCR and data represent the mean ligation stimulation conferred by a ribonucleotide, 
from 3 independent ligation reactions with error bars representing s.d. (E) Structural 
models and sugar puckers of substrates used in Fig. 3C to assess the mechanism by 
which ribonucleotides benefit complex end ligation. (F-H) Rosa26-targeted Cas9 RNP 
was introduced into MEF cells as in Fig. 2C-D, along with nucleotide triphosphates as 
indicated. Genomic DNA was harvested 1 hour after transfection. (F) TdT-specific +GG 
product was detected and analyzed as in Fig. 2C-D. (G) The targeted locus was 
amplified by PCR and digested with XbaI to remove non-mutated products. Mutated 
products were quantified as the mean ratio of XbaI-resistant amplicon in 3 independent 
transfections with error bars representing s.d. (H) Tracking of Indels by DEcomposition 
(TIDE) was performed on recovered repair products. Briefly, the targeted locus was 
amplified and sanger sequenced, and sequence degeneration was used to quantify 
insertions and deletions from 3 independent transfections. 
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# Joining efficiency rC/joining efficiency dC, as measured by qPCR that amplifies all 
NHEJ products.  
*Direct ligation product was undetectable 
+Ligation stimulation=Relative joining efficiency multiplied by %Direct ligation rC/%Direct 
ligation dC 
 
Table 3.1: Stimulation of NHEJ repair pathway by a terminal ribonucleotide 
 
 
 
 
 
 
 
 
 
 
 
 
 
Substrate Terminal C 
Relative Joining 
efficiency# 
% Direct 
ligation 
Ligation 
Stimulation+ 
 --GC  [--      
 --]  CG--   
deoxyC 1 87 ± 6 1 
(ribo)C 1.2 ± 0.7 92 ± 1 1.3 
--GAC  [--     
--]     AG-- 
deoxyC 1 19 ± 8 1 
(ribo)C 5.8 ± 1.9 88 ± 6 26 
2’fluoroC 5.4 ± 3.9 88 ± 1 25 
arabinoC 1.1 ± 0.6 < 2* < 0.1* 
--GCAGC  [-- 
--]     GCAG-- 
deoxyC 1 32 ± 3 1 
(ribo)C 6.3 ± 3.1 88 ± 3 17 
--TTTTTTTTGC  [-- 
--]                      G-- 
deoxyC 1 4 ± 1 1 
(ribo)C 3.0 ± 0.9 64 ± 5 48 
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5’ flank Insertion 3’ flank Frequency % (sd) 
TCTTTCTAGA  AGATGGGCGG +TdT (sd) -TdT (sd) 
TCTTTCTAGA GG AGATGGGCGG 13 (1.1) 0.4 (0.16) 
TCTTTCTAGA CC AGATGGGCGG 5.2 (0.15) 0.2 (0.04) 
TCTTTCTAG-  AGATGGGCGG 4.2 (1.0) 32 (1.7) 
TCTTTCTAGA G AGATGGGCGG 4.4 (0.52) 0.3 (0.05) 
TCTTTCTAGA A AGATGGGCGG 3.3(0.31) 5.5 (0.51) 
TCTTTCTAGA  AGATGGGCGG 2.9 (0.15) 8.9 (3.5) 
TCTTTCTAG- GG AGATGGGCGG 2.4 (0.20) 0.1 (.007) 
TCTTTCT---  AGATGGGCGG 1.9 (0.61) 12.3 (0.6) 
TCTTTCTAGA AA AGATGGGCGG 1.7 (0.02) 0.09 (0.02) 
TCTTTCTAGA GGG AGATGGGCGG 1.6 (0.01) 0.05 (0.02) 
 
Table 3.2: Frequencies of Cas9-sgRosa26 repair products in TdT-expressing 
MEFs 
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Substrate Construction Oligonucleotides (5’ to 3’) *Italics = deoxy/ribo 
Core 
CAAGTGGTCTCAGACTGGCTACCCTGCTTCTTTGAGCATTTCTGAAACTATCACT
TGTGTTTATTATTACACTGGCATTCATTCTCCAGAGAACATGTCTAGCCTATTCCC
AGCTTTGCTTACGGAGTTACTCTGTATCTTTGCCTTGGAGAGTGCCAGAATCTGG
TTTCAGAGTAAGATTTTATACATCATTTTTAGACATAGAAGCCACAGACATAGACA
ACGGAAGAAAGAGACTTTGGATTCTACTTACGTTTGATTTCCCTGACGGAGACCT
CGGC 
Substrates Generated by PCR and Restriction Digest 
G Substrate Forward GTACCAAGTGGACCACATGTCTTAGCTGTA
TAGTCAGGGA 
G Substrate Reverse GTACGCCGCCGACGCCATGTCACACCCAT
CTCAGACTGGC 
C Substrate Forward CAAGTGGACCAGACGTCTTAGCTGTATAGT
CAGGGAAATC 
C Substrate Reverse CCGCCGACGCGACGTCACACCCATCTCAG
ACTGGCTACCC 
Substrates Generated by Cap Annealing and Ligation 
CG / CG Left Cap Top Strand AGTCTGAGATGGGTGTCATGC 
CG / CG Left Cap Bottom Strand ATGACACCCATCTCA 
CG / CG Right Cap Top Strand TGACTATACAGCTAAGGTCATGC 
CG / CG Right Cap Bottom Strand ATGACCTTAGCTGTATA 
CAG / AG Left Cap Top Strand AGTCTGAGATGGGTGTGTCGAC 
CAG / AG Left Cap Bottom Strand GACACACCCATCTCA 
CAG / AG Right Cap Top Strand TGACTATACAGCTAAGGTGTCGA 
CAG / AG Right Cap Bottom Strand GACACCTTAGCTGTATA 
CGCAG / GCAG Left Cap Top 
Strand 
AGTCTGAGATGGGTGCCACGACGC 
CGCAG / GCAG Left Cap Bottom 
Strand 
GTGGCACCCATCTCA 
CGCAG / GCAG Right Cap Top 
Strand 
TGACTATACAGCTAAGCCCACGACG 
CGCAG / GCAG Right Cap Bottom 
Strand 
GTGGGCTTAGCTGTATA 
CGTTTTTTTT / G Left Cap Top 
Strand 
AGTCTGAGATGGGTGTGCCATTTTTTTTGC 
CGTTTTTTTT / G Left Cap Bottom 
Strand 
TGGCACACCCATCTCA 
CGTTTTTTTT / G Right Cap Top 
Strand 
TGACTATACAGCTAAGTGCG 
CGTTTTTTTT / G Right Cap Bottom 
Strand 
GCACTTAGCTGTATA 
PCR Primer Oligonucleotides 
PCR-Digest assay to detect extrachromosomal substrate repair products 
Forward Primer CTTACGTTTGATTTCCCTGACTATACAG 
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Reverse Primer GCAGGGTAGCCAGTCTGAGATG 
TaqMan assay to measure repair efficiency of extrachromosomal substrates 
Forward Primer CCACAGACATAGACAACGGAAG 
Reverse Primer ACACAAGTGATAGTTTCAGAAATGC 
Probe (FAM-ZEN) TCTCAGACTGGCTACCCTGCTTCT 
TaqMan assay for V(D)J recombination products at murine IgK locus 
Forward Primer GGTTTAGTGGCAGTGGGTCTGGGAC 
Reverse Primer CTTTGCCTTGGAGAGTGCCAGAATC 
Probe (FAM-ZEN) AGCCACAGACATAGACAACGGAAGA 
TaqMan assay for TdT-dependent CRISPR repair product (+GG) 
Forward Primer TCAGTTGGGCTGTTTTGGAG 
Reverse Primer GAAGACTCCCGCCCATCACC 
Probe (FAM-ZEN) TCAGTAAGGGAGCTGCAGTGGAGTA 
High-throughput sequencing library preparation 
Substrate Forward Primer (INDEX)CTTACGTTTGATTTCCCTGACTATA
CAG 
Substrate Reverse Primer (INDEX)GCAGGGTAGCCAGTCTGAGATG 
Adapter Top Strand GATCGGAAGAGCGGTTCAGCAGGAATGCC
GAG 
Adapter Bottom Strand ACACTCTTTCCCTACACGACGCTCTTCCGA
TCT 
Enrichment Forward Primer AATGATACGGCGACCACCGAGATCTACAC
TCTTTCCCTACACGACGCTCTTCCGATCT 
Enrichment Reverse Primer CAAGCAGAAGACGGCATACGAGATCGGTC
TCGGCATTCCTGCTGAACCGCTCTTCCGAT
CT 
SYBR Green assay to detect unrepaired and repaired extrachromosomal substrates 
Forward Primer GGCACTCTCCAAGGCAAAGA 
Reverse Primer ACATGTCTAGCCTATTCCCGGCTT 
PCR Primers to amplify targeted Rosa26 locus for product structure analysis 
Forward Primer GGCGGATCACAAGCAATAAT 
Reverse Primer TCAGTTGGGCTGTTTTGGAG 
sgRNA Targets *lower case = PAM 
Mouse Rnaseh2a Target Guide 1 GCCACTTTCCCCACGGGCCTagg 
Mouse Rnaseh2a Target Guide 2 TTTCTGCAGCCTGGGCAGACagg 
Mouse Polm Target Guide 1 CAAGGTAGATGGCCACATCCggg 
Mouse Polm Target Guide 2 CGCGAATGGGCCGCAGCCGCcgg 
Mouse Rosa26 Target Guide ACTCCAGTCTTTCTAGAAGAtgg 
 
Table 3.3: Sequences of DNA Reagents 
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CHAPTER 4: DISCUSSION 
 
Chromosomal double strand breaks are highly toxic genomic lesions that play a 
central role in human health and disease. These highly heterogeneous breaks often 
have associated distortions that block repair. The NHEJ pathway overcomes this 
daunting challenge in a unique way, as it is the only repair pathway that does not utilize 
extensive resection to bypass the problem of substrate diversity4. Instead, NHEJ 
enzymes have evolved remarkable mechanistic flexibility. The NHEJ ligase and 
polymerases are the most flexible enzymes of their respective classes, in terms of their 
ability to engage a wide range of unorthodox substrates that other ligases and 
polymerases cannot act upon5. The basis of this flexibility and its importance for 
biological DSB repair were unknown. 
My research has uncovered two mechanisms employed by NHEJ enzymes to 
address the challenge of substrate diversity: a DNA ligase that promotes a more mobile 
repair complex, allowing for flexible repair, and two “DNA” polymerases that actually use 
RNA to allow ligation of otherwise irreparable breaks. In Chapter 2, my work shows that 
LIG4 is specialized to directly ligate broken ends with adjacent damage and mispairs; 
that this specialization is attributable to an increase in the repair complex’s mobility; and 
that this flexibility promotes cellular resistance to ionizing radiation. I present data in 
Chapter 3 revealing that pol µ and TdT are actually RNA polymerases in cells; that their 
RNA incorporation confers a ligation advantage to LIG4; and that this mechanism alters 
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the repair efficiency and product structures of CRISPR-Cas9 induced breaks. Taken 
together, my findings provide a clear picture of two novel mechanisms that facilitate 
repair of diverse chromosome breaks, establishing these mechanisms as central to the 
critical biological functions of the NHEJ pathway. 
 
4.1 Tolerance of Mispairs and Damage at the Ligation Step 
 The final step in NHEJ is the rejoining of ends by LIG4, which is the only DNA 
ligase that acts in this pathway52. By directly comparing joining activity of different 
ligases on complementary and incompatible ends, previous in vitro studies have 
demonstrated that LIG4 is more tolerant of mispaired ends than other ligases60. My 
work identifies the mechanistic basis of this specialized activity: I report that LIG4’s 
ability to join damaged and mispaired ends requires a conserved structural element, 
insert1, that is fully unique to this ligase (Figure 2.1B, Figure 2.5, Figure 2.6). 
A major limitation of previous studies of DNA ligases in end joining is that these 
studies have compared ligases in the absence of other factors60,126. However, biological 
activity of LIG4 requires Ku, XRCC4, and XLF; other ligases do not interact with these 
proteins. To address this shortcoming, I generated a chimeric DNA ligase consisting of 
the catalytic core of LIG3 and the interaction domains of LIG4 (Figure 2.2E). I found that 
this chimera interacts with other NHEJ proteins and maintains full activity on 
complementary ends, but that it is even more impaired than LIG4Δi on ends with 
associated damage (Figure 2.2E). My work is thus the first to compare the NHEJ activity 
of different DNA ligases. 
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4.2 Structural Basis of Damage Tolerance 
My data suggest that other structural elements of LIG4 contribute to damage 
tolerance and provide a starting point for a detailed interrogation of ligase biochemistry 
(Figure 2.2E). The clear next step in this line of investigation is the generation of 
additional chimeric ligases from each of the 3 catalytic domains of LIG1, LIG3, and 
LIG4. Instead of substituting the entire catalytic core, individual domains can be fused to 
isolate each potentially significant part of the enzyme. Studies of LIG1 further suggest 
that activity can be reconstituted by adding the domains of ligases in trans56.  
Of particular interest are the adenylation domain that contains the active site and 
the DNA binding domain of LIG4 that contains insert1, since I show that this insert is 
particularly important for joining complex end structures. With respect to insert1, I 
propose that it acts as a hinge to help LIG4 maintain a closed, substrate-bound 
conformation via protein-protein interactions between insert1 and the OB-fold domain. 
This proposition generates testable hypotheses about mutating residues opposite 
insert1 in the OB-fold domain, or substituting the OB-fold domain of LIG4 with that of 
another ligase.  
Our understanding of LIG4 has been limited by the lack of a substrate-bound 
crystal structure. My work predicts that such a structure would confirm an important role 
for insert1. Arginine 113 is the most conserved residue in insert1 and is identical in LIG4 
from humans to plants (Figure 2.2A); it could be solely responsible for the effects of the 
LIG4Δi mutant. 
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4.3 Mobilization of Ends within Repair Complexes 
 Formation of the NHEJ paired end complex (PEC) implicitly involves the bridging 
of DSB ends by NHEJ proteins. Previous studies have identified core NHEJ factors as 
essential for this end bridging, including Ku, LIG4, XRCC4, and XLF46–49. Super-
resolution imaging of fixed cells has confirmed these studies and additionally identified 
the role of multiprotein filaments that form along the break site and assist in end 
bridging51. Interestingly, the role of LIG4 in end bridging is distinct from its ligation 
activity, as a catalytic dead LIG4 which cannot ligate can still bridge ends in pulldown 
assays109.  
My work builds upon these foundational studies to establish LIG4 as a “sensor” 
of end chemistry within PECs. In response to differences in end structure, LIG4 
mobilizes the entire PEC to induce dramatic changes in the conformation of the ends 
(Figure 2.3C-D, Figure 2.4). This mobilization also enables LIG4 to join damaged and 
mispaired end structures, and both activities require insert1 (Figure 2.1B, Figure 2.5, 
Figure 2.6). Unexpectedly, I found that LIG4 enables nucleolytic processing of 3’ flaps, 
indicating that LIG4 can tailor processing steps based on end structure (Figure 2.7, 
Figure 2.8). Moreover, FRET states observed in single molecule analysis suggest that 
LIG4 physically extrudes these flaps so that a nuclease can clip them (Figure 2.7C). A 
previous in vitro study suggests Artemis may be the nuclease responsible for this 
clipping in cells67. My data provide a clear substrate context for testing this hypothesis. 
I proposed that insert1 allows LIG4 to maintain a closed, substrate-bound 
conformation, and that this closed conformation allows for increased PEC mobility in 
response to differences in end structure. Further analysis of single molecule dynamics 
  83 
within PECs could test this hypothesis directly. The DNA binding domain and OB-fold 
domain are the domains furthest apart within the ligase catalytic core. Each could be 
tagged with FRET probes to discern between open and closed conformations, in the 
presence or absence of insert1, and these conformations could then be directly linked 
with PEC mobility. 
 
4.4 Biological Significance of Ligation Flexibility 
 Since NHEJ is the only pathway that repairs damaged and mispaired ends 
without resection, there has been significant interest in identifying factors required for 
this unique activity. This prior work has implicated NHEJ polymerases, nucleases, 
PAXX, and filaments formed by XRCC4 and XLF in repair of complex ends33,59,67,72,103–
106. Attempts to test the role of LIG4 in complex end repair have focused on in vitro 
systems that fail to recapitulate the genetic requirements for NHEJ60,126. My work is the 
first to assess the biological contribution of LIG4 specialization to complex end repair in 
cells.  
 The biopharmaceutical research community has significant interest in drugging 
DNA ligases as cancer therapy agents, including LIG4111. In fact, targeting DNA repair 
machinery has already shown success in treating cancers with inborn DNA repair 
defects, such as BRCA-defective diseases127. Development efforts have focused on the 
potential of these drugs to sensitize tumors to ionizing radiation. To this end, I have 
shown that cells lacking LIG4 insert1 are extremely sensitive to ionizing radiation 
(Figure 2.9, Figure 2.10). Insert1 thus presents a promising therapeutic target; since it is 
  84 
completely unique to LIG4, it is less likely to engender the off-target effects seen with 
existing ligase inhibitors112.   
 Single molecule dynamics revealed that LIG4 enables mobilization of ends in 
response to differences in end chemistry, and analysis of cellular sensitivity to 
damaging agents revealed that this mobilization is critical for repair in biological 
contexts. My work suggests that the dynamic alignment of two DSB ends within the 
paired end complex can ultimately affect whether a cell will live or die as a result of a 
break (Figure 2.11).  
 
4.5 Pol µ and TdT are RNA polymerases in cells 
 In addition to using a ligase specialized to join diverse end structures, NHEJ has 
evolved the ability to employ 3 X-family DNA polymerases to process ends and thereby 
render substrates more amenable to ligation69. Traditional RNA-DNA transactions 
adhere strictly to the central dogma of molecular biology: DNA is transcribed into RNA 
via templated synthesis. The most noteworthy exception is synthesis in the opposite 
direction, synthesizing DNA from an RNA template128,129. Other exceptions, including 
use of RNA as a primer for DNA synthesis, carefully avoid incorporating RNA into the 
genome130.  
Two of NHEJ’s specialized polymerases, pol µ and TdT, have highly unusual 
biochemical properties, including uniquely poor discrimination against ribonucleotides in 
vitro37,87–90. The studies presented here show that pol µ and TdT are primarily RNA 
polymerases during the repair of chromosome breaks in cells (Figure 3.4). This finding 
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is significant because it is the first example of RNA being preferentially incorporated into 
a DNA genome.  
 
4.6 NHEJ and Ribonucleotide Excision Repair 
 The preferential incorporation of RNA into the mammalian genome by NHEJ 
polymerases was unanticipated because genomic ribonucleotides are toxic to cells86. 
RNA is more reactive than DNA; its labile 2’ hydroxyl group leaves the genome 
vulnerable to hydrolytic breakage and thus embedded RNA contributes to genome 
instability86. To address this problem, evolution has produced the ribonucleotide 
excision repair (RER) pathway mediated by a heterotrimeric ribonuclease, RNase H286. 
 The primary cellular role of the RER pathway is thought to be repair of RNA 
incorporated by replicative polymerases during genome synthesis. Our data identify a 
novel role for RER in the removal of ribonucleotides incorporated by pol µ and TdT 
during chromosome break repair (Figure 3.1B, Figure 3.4B, Figure 3.6D). RNase H2 
carries out its role in NHEJ rapidly; RNA-containing products of extrachromosomal 
repair are undetectable after only 20 minutes (Figure 3.1B). The speed of RNA removal 
could be attributable to a physical interaction between NHEJ complexes and RNase H2. 
Such interactions could readily be assessed with pulldown assays in cells and 
electrophoretic mobility shifts in vitro. It also remains unclear if RER functions in this 
new context as it does outside of NHEJ: in canonical RER, strand displacement 
synthesis and ligation follow the RNase H2-mediated nicking of the ribonucleotide 5’ 
terminus86. 
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 Perhaps the most significant implication of the NHEJ-RER interaction is the 
potential for a triple strand break repair model in which the first strand is repaired using 
RNA, the second (opposite) strand is repaired with only DNA, and the original first 
strand is then repaired again by RER (Figure 3.7E). We propose that second strand 
repair precedes RER because RNase H2 would re-introduce the double strand break 
unless the second strand is repaired before RER. This model generates testable 
hypotheses about the regulation of RNase H2: its activity must be stalled by some 
mechanism until the second strand is repaired. 
 
4.7 Ribonucleotides Enable Ligation 
 Since ribonucleotide incorporation can potentially destabilize the genome, we 
reasoned that it might carry some benefit to NHEJ that offsets its potential costs. 
Indeed, we found that terminal ribonucleotides enable ligation of ends with adjacent 
mispairs both in vitro and in cells (Figure 3.7B, Figure 3.8C, Table 3.1). Furthermore, if 
a deoxynucleotide is incorporated instead of a ribonucleotide, such ends are repaired 
less efficiently and less accurately (Figure 3.8A-B, Table 3.1). I further demonstrated 
that this effect is specific to LIG4: T4 bacteriophage ligase does not receive any ligation 
benefit from a terminal ribonucleotide in vitro (Figure 3.8C). Future work will identify the 
mechanistic basis of LIG4 specialization for 3’ terminal ribonucleotides. To this end, my 
experiments from Chapter 2 provide a framework for interrogating structural elements 
and activities unique to this ligase. 
 In existing crystal structures of DNA ligases, nucleotides around the DNA nick 
are twisted from their normal B-form (B-DNA) into the noncanonical, RNA-like A-form 
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(A-DNA)131. This structural conformation closely positions the unjoined 3’ and 5’ termini 
and may be required for the chemistry of ligation. The transition from B-DNA to A-DNA 
is attributable to the sugar pucker of the nucleotides involved: an RNA-like C3’-endo 
sugar pucker promotes A-DNA, while a DNA-like C2’-endo pucker promotes B-DNA131. 
To test if this mechanism is involved in ribonucleotide stimulation of LIG4, we generated 
substrates with terminal cytarabine (Ara-C) nucleotides (Figure 3.8E). Ara-C differs from 
ribo-cytidine (ribo-C) only in the chirality of its 2’ center, and thus adopts a DNA-like C2’-
endo pucker. In accordance with structural studies, we found that Ara-C termini fully 
block direct ligation of NHEJ substrates (Figure 3.7C). Ara-C is a commonly used 
cancer therapy agent and future studies will elucidate whether its incorporation into 
NHEJ substrates is a potential mechanism of action132. 
 
4.8 Ribonucleotides in CRISPR-Cas9 Repair Products 
 Targeted endonucleases have proven useful for precisely editing the genome. In 
particular, there has been tremendous interest in modifying the CRISPR-Cas9 system 
to alter DSB induction by Cas9 and repair by the cellular machinery20,21. Because the 
majority of Cas9-induced breaks are repaired by NHEJ in mammalian cells, inhibition of 
the NHEJ pathway has been investigated as a way of modulating genome engineering 
outcomes133. I found that adding deoxy- or ribonucleotides to cells expressing TdT can 
alter the efficiency and accuracy of repair of Cas9-induced breaks (Figure 3.7D, Figure 
3.8F-H). Specifically, ribonucleotides increase the recovery of specific TdT-dependent 
insertions, while deoxynucleotides impair recovery of mutated repair products 
altogether. 
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 I assessed repair at early time points because nucleotide pool perturbations are 
necessarily transient in mammalian cells134. A deeper kinetic profile of the effect of 
nucleotide supplementation on Cas9 repair products would yield useful insight. Deletion 
products accumulate more slowly than insertion products in NHEJ11; do deletions thus 
rescue the inhibitory effect of deoxynucleotides at later time points, does nucleotide pool 
stabilization diminish the effect of nucleotide supplementation, or is the inhibitory effect 
durable over time? Sequencing of repair products recovered from cells with or without 
NHEJ polymerases supplemented with different nucleotides would also help assess the 
significance of this Cas9-induced break repair phenomenon.  
 
4.9 Biotechnology Applications 
 Further experimentation will also focus on the development of this strategy as a 
biotechnology tool for genome engineering. Of particular interest is the fact that both pol 
µ and TdT recombinant protein can be purified in milligram quantities and 
electroporated into cells intact and active, along with nucleotide triphosphates. My 
experiments were performed in cells expressing TdT, warranting further 
experimentation with recombinant protein electroporation. These proteins can also be 
introduced at levels vastly exceeding what can be expressed in cells. The impact of 
ribonucleotides and deoxynucleotides on repair may be responsive to increases in 
polymerase concentration.  
 I showed that supplementation with ribonucleotides increases the recovery of a 
single, specific, polymerase-dependent repair product (Figure 3.7D). Therefore, TdT 
and ribonucleotides could potentially be used to site-specifically engineer 1-3 base pair 
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insertions of a desired nucleotide into the genome. If this proves effective, it could 
become simple to introduce targeted early stop codons. TdT is also appreciated in 
molecular biology for its ability to incorporate derivatized nucleotides in vitro135,136. 
Harnessing my results, these experiments can potentially be done in cells to incorporate 
a desired derivatized nucleotide into a specific genomic site. 
 
4.10 Concluding Remarks 
 To preserve the integrity of the genome, the NHEJ pathway must repair double 
strand breaks with a variety of end structures. The work presented in this dissertation 
identifies two mechanisms that allow this pathway to carry out repair with remarkable 
flexibility. I found that the NHEJ ligase is uniquely adapted to work on highly unusual 
substrates, and that this adaptation is essential for cells to survive genomic damage. I 
also showed that NHEJ—bizarrely—incorporates RNA into the genome to achieve 
repair of otherwise irreparable breaks. Both of these mechanisms are integral for NHEJ 
to overcome its central challenge: the repair of complex breaks. In addition to advancing 
the field of DNA repair, my findings have clear and direct biotechnology applications. 
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